Paediatrics · Full case

CMPA & Infant Reflux

NICE NG1iMAPMAP Guidelines
CM
CMPA & Reflux in Children · Clinical Reasoning Framework v2
GP & SCA · NICE NG1 · iMAP · MAP Guidelines · IgE vs non-IgE · eHF · AAF · Milk Ladder · Infant Gaviscon · GORD
IgE: <2h; non-IgE: 2–72h after milk exposureThe IgE vs non-IgE distinction is the most clinically important in CMPA. IgE-mediated: immediate reactions (within 2 hours of milk ingestion): urticaria; angioedema; vomiting; wheeze; anaphylaxis; requires allergy testing (skin prick test; specific IgE) and adrenaline auto-injector prescription. Non-IgE-mediated (more common; 60–70% of CMPA): delayed reactions (2–72 hours): GI symptoms (colic; vomiting; diarrhoea; green stools; constipation); eczema; faltering growth. No reliable allergy test for non-IgE-mediated — diagnosis is clinical, based on history and response to elimination trial.
eHF first-line formula for CMPA — NOT HA formulaExtensively hydrolysed formula (eHF) is the the iMAP (Milk Allergy in Primary Care) guideline first-line formula for cow’s milk protein allergy in formula-fed infants. Examples: Nutramigen 1 with LGG; Aptamil Pepti 1; SMA Althera; Similac Alimentum. NOT appropriate: partially hydrolysed formula (HA formula e.g. SMA HA; Aptamil Comfort) — not sufficiently hydrolysed for CMPA diagnosis or treatment; NOT goat’s milk formula (major cross-reactivity with cow’s milk; not suitable for CMPA); NOT soy formula in infants under 6 months (phytoestrogens; concerns about infant development); soy from 6 months is an option for non-IgE-mediated CMPA (10–14% cross-react with soy).
Breastfed infant with CMPA: maternal dairy-free diet (not formula)If CMPA is suspected in a breastfed infant: the intervention is a maternal dairy-free diet for 2–4 weeks — the infant continues breastfeeding. Do NOT switch a breastfed infant to formula for CMPA investigation — breastfeeding should be supported and continued. Mother: calcium supplementation (1000mg/day) + vitamin D (10 mcg/day) during dairy-free diet. Soy milk is acceptable for the mother (not the infant under 6 months). If maternal dairy-free diet leads to symptom improvement in the infant after 2–4 weeks: CMPA confirmed; continue dairy-free breastfeeding; specialist referral (allergy team or paediatric dietitian) for milk ladder guidance.
Diagnosis non-IgE CMPA: elimination 2–4 weeks → rechallengeNon-IgE-mediated CMPA has no reliable allergy test: skin prick tests and specific IgE are negative (by definition — no IgE involvement). Diagnosis is made clinically: (1) Symptoms consistent with non-IgE-mediated CMPA; (2) Trial of cow’s milk elimination for 2–4 weeks (formula change to eHF; or maternal dairy-free diet); (3) Symptom improvement during elimination; (4) Rechallenge with cow’s milk at the end of the trial — if symptoms return, CMPA is confirmed. The controlled milk rechallenge (or reintroduction via the milk ladder at 6–12 months) is essential — CMPA should not become a permanent diagnosis without confirmation.
GOR is physiological in 70% of infants — peak at 4 monthsGastro-oesophageal reflux (GOR) is very common in infants: approximately 70% of infants spit up regularly; peak prevalence at 4 months; resolves spontaneously in most infants by 12–18 months as the lower oesophageal sphincter matures. “Happy spitters”: reflux with no distress, no faltering growth, no complications — parental reassurance is the appropriate management. GORD (GOR ‘Disease’): reflux causing complications — faltering growth; significant pain; aspiration; recurrent respiratory infections; dental erosion. Omeprazole: ONLY indicated for confirmed GORD with complications — NOT for simple GOR; NOT as diagnostic trial.
CMPA: 2–3% incidence; 90% resolve by age 5Cow’s milk protein allergy affects 2–3% of infants. The majority of children with non-IgE-mediated CMPA (the most common type) develop tolerance by age 3–5 years: 60% resolve by age 2; 80% by age 3; 90% by age 5. IgE-mediated CMPA: persists longer; may coexist with other atopic conditions (eczema; asthma; hay fever). Milk ladder: structured stepwise reintroduction of milk products, starting with baked milk (highest temperature processing reduces allergenicity). Most children with non-IgE-mediated CMPA tolerate well-cooked milk products within 12–18 months. Milk ladder should be supervised by allergy team in IgE-mediated cases (risk of anaphylaxis on rechallenge).
Omeprazole NOT for simple GOR in infants — GORD onlyProton pump inhibitors (omeprazole; lansoprazole) are not indicated for physiological infant GOR and are frequently over-prescribed. Evidence: multiple randomised controlled trials show PPIs are no more effective than placebo for non-GORD crying/distress in infants. Appropriate use: confirmed GORD with complications (faltering growth; oesophagitis; recurrent aspiration). NICE NG1: consider PPI only if GOR is causing complications after lifestyle measures and alginate have been tried. Dose: omeprazole 0.7–1.4 mg/kg/day (maximum 20mg in infants). Note: if CMPA is causing reflux-like symptoms, omeprazole treats the wrong diagnosis — the correct treatment is formula change to eHF.
Faltering growth + eczema + atopy → suspect CMPA not just GORThe combination of reflux-like symptoms PLUS any of the following should raise strong suspicion of CMPA rather than simple GOR: faltering growth (dropping centiles); atopic dermatitis (eczema); strong family history of atopy (at least one first-degree relative with asthma; hayfever; eczema; food allergy); blood or mucus in stools; green watery stools; significant colic unresponsive to standard management; failure to respond to Infant Gaviscon or thickened feeds; onset of symptoms in first few weeks of life after formula introduction. If three or more of these features are present: CMPA is the working diagnosis; change formula to eHF; review in 2–4 weeks. Do not use partially hydrolysed formula as a diagnostic test.
📋 Clinical Stem — CMPA & Reflux in Children
Baby Priya, 4 months, formula-fed, with persistent crying after feeds, green watery stools, cheek eczema, faltering from 50th to 25th centile, and two failed courses of Infant Gaviscon, brought by an exhausted first-time mother
Mrs. Anita Sharma, 28, brings her 4-month-old daughter Priya. Priya has been formula-fed on SMA First since 2 weeks of age when breastfeeding was discontinued due to latching difficulties and mastitis. She was born at term weighing 3.8 kg (50th centile). She is now 4.2 kg (25th centile) — she has crossed one centile down. From 3 weeks of age she has had persistent crying and back-arching after feeds, vomiting (one to two times per feed), and green watery stools. She has developed eczema on both cheeks. Mrs. Sharma’s husband has asthma; Mrs. Sharma herself has hay fever. The health visitor advised Infant Gaviscon two months ago and a second course last month. Neither has helped. There is no bilious vomiting; no blood in stools; no apnoea; no fever. Mrs. Sharma has been sleeping approximately 4–5 hours per night broken sleep since Priya was born. She feels guilty about stopping breastfeeding and is worried she has done something wrong.
This stem tests the ability to distinguish non-IgE-mediated cow’s milk protein allergy from physiological gastro-oesophageal reflux. The key discriminators are present: faltering growth (50th → 25th centile); atopic dermatitis (eczema on cheeks); family atopy (paternal asthma; maternal hay fever); green watery stools; failure of Infant Gaviscon ×2; early age of symptom onset (3 weeks). The SCA challenge is to make the diagnosis of CMPA, prescribe eHF formula (not HA/partially hydrolysed), explain why Infant Gaviscon was not wrong but is no longer enough, address Mrs. Sharma’s guilt about stopping breastfeeding, and provide a clear 2–4 week plan with follow-up while supporting a visibly exhausted mother.
Scenario A — IgE-mediated CMPA Baby Charlie, 8 weeks, formula-fed from birth. After first bottle of standard formula: immediate urticaria; lip swelling; vomiting within 20 minutes; inconsolable. Brought to emergency GP appointment. IgE-mediated CMPA: immediate reaction (<2 hours), allergy features (urticaria; angioedema). Actions: no further cow’s milk formula; switch to amino acid formula (AAF) immediately (Neocate; Alfamino — eHF may not be safe for IgE-mediated until allergy test clarifies); URGENT allergy referral for skin prick testing; adrenaline auto-injector (EpiPen Junior 150 mcg) prescribed if any risk of anaphylaxis; written allergy action plan; 999 if any anaphylaxis features (wheeze; hypotension; loss of consciousness). Do NOT try eHF until allergy testing clarifies tolerance.
Scenario B — Breastfed infant with CMPA Baby Noah, 6 weeks, exclusively breastfed. Persistent crying; blood-streaked green mucousy stools; poor weight gain. Mum has been eating normally. Intervention: maternal dairy-free diet for 2–4 weeks — NOT formula change (continue breastfeeding). Mum needs calcium 1000mg/day + vitamin D 10 mcg/day supplementation during dairy-free diet. If symptoms resolve in 2–4 weeks: confirm CMPA; continue dairy-free breastfeeding; paediatric dietitian referral for weaning guidance and milk ladder planning. If symptoms do NOT resolve: reconsider diagnosis; consider soy exclusion (CMPA + soy allergy co-exist in 10–14% of cases); exclude other causes (rotavirus; sepsis in younger infant).
Scenario C — Simple physiological GOR (happy spitter) Baby Lily, 3 months, formula-fed. Frequent posseting after feeds (one to two tablespoons each time). No distress; no crying; no arching. Weight tracking on 75th centile (consistent since birth). No eczema; no family atopy. Stools normal. Mum is worried. Diagnosis: physiological GOR — not CMPA; not GORD. Management: parental reassurance (most common and most important intervention); explanation of what normal infant reflux is and when it resolves (12–18 months); practical advice (smaller more frequent feeds; upright for 20–30 minutes after feeds). Infant Gaviscon: can be tried if mum is concerned; thickened feeds (SMA Staydown; Carobel). No formula change; no omeprazole; no allergy investigation. Review at 6 months — if still problematic: further assessment.
Scenario D — GORD with complications Baby Marcus, 5 months, formula-fed. Significant distress with feeds; back-arching; iron-deficiency anaemia; faltering growth (dropped 2 centiles); recurrent respiratory tract infections (aspiration episodes). GORD with complications: a different clinical picture from simple GOR. Management: alginate (Infant Gaviscon) first; if inadequate: PPI (omeprazole 0.7–1.4 mg/kg/day); consider CMPA as concurrent cause (trial eHF alongside); urgent paediatric gastroenterology referral (possible pH study; endoscopy). Do NOT use PPI alone without considering CMPA as concurrent or alternative diagnosis.
Scenario E — Failing on eHF; consider AAF Baby Lara, 6 months, previously diagnosed with non-IgE-mediated CMPA, changed to eHF (Nutramigen) 4 weeks ago. Symptoms persisting (green stools; crying; eczema worse). Next step: assess adherence (are all milk-containing products excluded?); if confirmed adherent: switch to amino acid formula (AAF: Neocate Infant; Alfamino); all dairy must be excluded from maternal diet if breastfed. Re-refer to paediatric allergy team. 10–14% of CMPA also have soy allergy — consider excluding soy from diet too if AAF not working. If no improvement on AAF: paediatric gastroenterology review; other diagnoses (IBD; other food allergy; malabsorption).
Key variables to adapt for Feeding method (formula vs breastfed — different interventions; breast ⇒ maternal dairy-free diet; formula ⇒ eHF; never switch from breast to formula for CMPA investigation); IgE vs non-IgE clinical picture (immediate vs delayed reaction; allergy testing indicated vs not; adrenaline prescription vs elimination trial); severity (anaphylaxis ⇒ 999; faltering growth ⇒ urgent referral; mild symptoms ⇒ GP-managed); age (under 6 months: no soy formula; over 6 months: soy option; weaning timing affected); comorbid atopy (eczema management alongside CMPA); maternal wellbeing and guilt about stopping breastfeeding; parental anxiety and internet self-diagnosis
Steps:
1
Step 1
History Taking — Feeding Method · Symptom Timing · Atopy · Stool · Weight · Maternal Wellbeing
collapse
The history in suspected CMPA is the diagnosis: there is no reliable allergy test for non-IgE-mediated CMPA. The clinical picture — symptom timing relative to milk introduction; the presence of atopic features; the feeding method; the stool character; the weight trajectory; and the response to previous treatments — together determine whether this is physiological GOR, CMPA, GORD with complications, or a combination. Mrs. Sharma is exhausted and guilty. The GP who spends 30 seconds acknowledging this before the clinical history will get a better history and a better patient relationship.
🎓 SCA opener — acknowledge the mother before the symptoms
"Before we go through everything, I just want to say — you look like you have been having a really tough time. Four months of a baby who is crying and not settling is exhausting. You are clearly doing everything you can. Let’s have a proper look at what is going on together."
SCA: this acknowledgement costs 20 seconds and returns enormous dividends. Mrs. Sharma is carrying guilt about stopping breastfeeding, sleep deprivation, and anxiety about whether something serious is wrong. A GP who goes straight to the symptom checklist will get a defensive, anxious mum who holds back details she thinks might make her look like a bad mother. A GP who acknowledges the human situation first will get an open, detailed, accurate history.
1A — Open question, then targeted CMPA history
QuestionWhy it mattersChanges what?
🏲 OPEN QUESTION"Can you tell me in your own words what has been happening with Priya since she was born — everything you are worried about?"The open question in a CMPA consultation serves a dual purpose. Clinically: it allows Mrs. Sharma to describe the full symptom picture, including details she might otherwise edit out if asked closed questions. The timing, character, and context of symptoms often emerge naturally in a narrative that would never emerge from a checklist. And critically: Mrs. Sharma will lead with what worries her most. If she leads with the eczema — atopy is at the forefront of her mind. If she leads with the green stools — that tells you the stool change is the most alarming feature. Psychologically: the open question removes the dynamic where Mrs. Sharma is being interrogated and replaces it with one where she is collaborating. She has been managing this for 4 months — she knows more about Priya’s symptoms than any checklist will reveal.SCA: Global Skills for data gathering in a paediatric presentation; Relating to Others for mother-centred approachFull clinical picture emerges; Mrs. Sharma’s priorities revealed; guilt and concerns identified
Timing of symptom onset and relationship to formula introduction"When exactly did the symptoms start? And when did you switch from breast to formula?"This is the most diagnostically important question in the CMPA history. The temporal relationship between cow’s milk introduction and symptom onset is the cornerstone of the clinical diagnosis. Priya started formula at 2 weeks; symptoms started at 3 weeks. The 1–2 week delay is characteristic of non-IgE-mediated CMPA (delayed type): symptoms emerge 2–72 hours after each feed, and the pattern takes a week or two to become recognisable. This temporal pattern distinguishes CMPA from birth-onset causes (congenital; surgical) and from later-onset causes (weaning-related; viral). Crucially: if symptoms started at the same time as formula introduction (within 24 hours), IgE-mediated CMPA must be considered — immediate reactions.Onset at 3 weeks (1 week after formula): non-IgE-mediated pattern; elimination trial appropriate. Onset within hours of formula: IgE-mediated; urgent allergy referral; AAF not eHF
Stool character — colour; consistency; frequency; blood or mucus"Can you describe Priya’s stools? What colour? Watery or formed? Any blood or mucus? How often?"Stool character is a key discriminator in infant CMPA. Green watery stools: characteristic of non-IgE-mediated CMPA (gut inflammation from the immune reaction); also seen in foremilk/hindmilk imbalance (less relevant in formula-fed infant) and rotavirus (but would have fever and different clinical picture). Bloody mucousy stools: CMPA with proctitis/colitis — blood in stool in a formula-fed infant under 6 months is a red flag for CMPA until proven otherwise. Pale acholic stools: biliary atresia — emergency. Normal yellow stool: makes CMPA less likely; consider physiological GOR or GORD. Constipation: also occurs in non-IgE-mediated CMPA. The stool character, alongside the other features, helps distinguish CMPA from simple GOR (in which stools are usually normal).Green watery: non-IgE-mediated CMPA; eHF. Blood/mucus: CMPA colitis; urgent referral; AAF. Pale/acholic: biliary atresia; 999
Atopic features — eczema; family history of atopy"Has Priya developed any skin rashes or dry patches? And does anyone in the family have asthma, hayfever, eczema, or food allergies?"Atopic features are the strongest discriminator between CMPA and simple physiological GOR. A family atopy score (FAS) of ≥2 affected first-degree relatives dramatically increases CMPA probability. Priya has cheek eczema AND a father with asthma AND a mother with hay fever — this is a very strong atopic background. The presence of atopic dermatitis in an infant with reflux-like symptoms should trigger CMPA as the working diagnosis. Mechanism: CMPA and atopic dermatitis are closely linked — cow’s milk protein is a common trigger for eczema in infants, and the eczema may improve on milk elimination. Atopy history does not diagnose IgE-mediated CMPA specifically (both IgE and non-IgE-mediated CMPA occur in atopic families) but it strongly supports CMPA over simple GOR.Eczema + family atopy: CMPA most likely; eHF trial warranted; allergy referral if IgE features. No atopy: GOR more likely; reassurance and alginate first
Weight and feeding adequacy"How much is she feeding? And do you know what she weighed at birth and at her last check?"Weight trajectory is a critical severity marker. Priya has dropped from 50th to 25th centile (approximately 1 centile crossing). This degree of faltering growth — while not severe — distinguishes this from physiological GOR (which does not cause growth faltering) and escalates the urgency. Growth faltering in the context of reflux-like symptoms and atopy makes CMPA the working diagnosis and triggers urgent dietitian referral and consideration of allergy team input. If centile drop is ≥2 centiles: paediatric referral. 1 centile drop (Priya): urgent review in 2–4 weeks after formula change; dietitian referral. Note: formula volume adequacy should also be assessed — inadequate formula intake is a common cause of poor weight gain and may coexist with CMPA.≥2 centile drop: urgent paediatric referral. 1 centile drop (Priya): urgent review; dietitian; allergy team. No growth faltering: CMPA less severe; eHF trial; review 4 weeks
1B — Red flags: infant symptoms requiring immediate action
🚨

Red Flags — immediate escalation; these are NOT CMPA until proven otherwise

Red flagWhy dangerousAction
Bilious (green/yellow) vomitingBilious vomiting in an infant: intestinal obstruction until proven otherwise — pyloric stenosis (non-bilious); malrotation with volvulus (bilious; surgical emergency); intussusception (with intermittent pain; redcurrant jelly stool). Bilious vomiting is not a feature of CMPA or simple GOR — it always requires same-day hospital assessment. Note: green watery STOOLS (as in Priya) are different from bilious VOMIT and are a CMPA feature. Do not confuse the two.999 or A&E now — surgical emergency until proven otherwise
Blood in vomit (haematemesis)Blood in vomit: oesophagitis from severe GORD; Mallory-Weiss tear from forceful vomiting; rarely — bleeding disorder or vascular malformation. In the context of CMPA: oesophagitis from severe reflux may cause blood-streaking. Any haematemesis in an infant requires same-day assessment — it is a marker of severity that changes management from GP-led to hospital-led.Same-day A&E assessment — needs endoscopy and specialist assessment
Apnoea or colour change during feedsApnoea during or after feeds: aspiration from severe GOR (laryngospasm reflex); cardiac arrhythmia; neurological (seizure). In the CMPA context: anaphylaxis can present with stridor and apnoea in IgE-mediated cases. Any episode of apparent life-threatening event (ALTE) or brief resolved unexplained event (BRUE) in an infant requires hospital assessment and monitoring. Not a feature Priya has — but must be actively asked about.999 — hospital admission; monitoring; respiratory and cardiac assessment
Faltering growth ∩ 2 or more centile crossingsTwo or more centile crossings in an infant (e.g. 50th to below 9th centile) indicates significant failure to thrive. In the context of CMPA: unmanaged CMPA causes malabsorption; caloric loss from vomiting and diarrhoea; and appetite suppression from pain. Severe growth faltering requires urgent paediatric assessment — not a 2–4 week eHF trial. The GP must also consider other causes: inadequate formula intake; neglect; organic causes (coeliac; metabolic; cardiac).Same-day or next-day paediatric referral — inpatient admission may be needed for nutritional rehabilitation and investigation
Urticaria; angioedema; wheeze; collapse within 2 hours of feedIgE-mediated anaphylaxis to cow’s milk protein: the most severe form of CMPA. Presents within 2 hours of milk ingestion. Features: urticaria; lip or facial swelling; vomiting (may be very rapid); wheeze/stridor; pallor; collapse. Not Priya’s presentation — but critical to ask specifically (“has she ever had any swelling; hives; difficulty breathing after a feed?”) as this changes management completely (AAF not eHF; EpiPen; urgent allergy referral; no milk rechallenge without allergy specialist).999 if acute anaphylaxis. Adrenaline auto-injector (EpiPen Junior 150 mcg) prescribed if anaphylaxis risk. Urgent allergy referral. No milk rechallenge without allergy team.
Pale/chalky/acholic stools (white or grey)Pale acholic stools: biliary atresia — an emergency surgical condition causing progressive obliteration of the bile ducts. Presents in the newborn period with jaundice; dark urine; pale stools. Prognosis depends on early Kasai portoenterostomy (before 60 days of age). Any infant with persistently pale or chalky stools requires same-day urgent referral (biliary atresia excluded) — not a CMPA diagnosis.Same-day urgent referral — biliary atresia; surgical emergency if confirmed
🛡️

Safeguarding and Maternal Wellbeing

Mrs. Sharma is a first-time mother who has been sleeping 4–5 hours broken sleep for 4 months, carrying guilt about stopping breastfeeding, and managing a persistently unwell infant. Postnatal depression (PND) affects 10–15% of women; rates are higher in women with infants who have chronic health problems including CMPA. The GP must assess Mrs. Sharma’s mental health alongside Priya’s physical health.
💕 Maternal Mental Health
  • Edinburgh Postnatal Depression Scale (EPDS): validated 10-item questionnaire; score ≥13 indicates probable PND; score ≥11 with any score on question 10 (self-harm): urgent mental health referral
  • Mrs. Sharma: risk factors for PND include sleep deprivation (4–5 hours broken); infant with chronic health problem; stopping breastfeeding (which may generate feelings of failure); anxiety about Priya’s health
  • Administer EPDS at this consultation; it takes 2–3 minutes and is a clinical requirement at postnatal reviews
  • Health visitor should have completed EPDS at 6–8 weeks review — check if this has happened and what the score was
🏠 Home and Social Situation
  • Is Mrs. Sharma’s husband supportive? Is he present at home? Does he do night feeds?
  • Is there family support (grandparents; neighbours)?
  • Is she isolated? First-time mother in a new area? Social support is protective against PND and infant neglect (which can occur through exhaustion and despair, not malicious intent)
  • Any domestic violence concerns? Domestic violence is a risk factor for poor infant outcomes; always ask — NICE-recommended routine enquiry
● Safeguarding — Non-Accidental Injury
  • A persistently crying infant is a well-recognised trigger for non-accidental injury (NAI); shaken baby syndrome has its peak incidence at 3–5 months of age — the peak age of infant crying
  • The “purple crying” period: normal infant crying peaks at 2–5 months; families need information about safe handling when a baby does not stop crying
  • Observe: does Mrs. Sharma handle Priya gently? Any features of concern on examination (bruising; unusual injury patterns; fractures on X-ray if admitted)?
  • If safeguarding concern: follow local safeguarding pathway; refer to safeguarding team and social services as appropriate
💕 Breastfeeding Guilt and Identity
  • Mrs. Sharma stopped breastfeeding at 2 weeks due to latching difficulties and mastitis — she did not choose to stop from lack of commitment; she was in pain and without adequate support
  • The guilt about stopping breastfeeding may be significant and should be directly addressed: “You stopped breastfeeding because you were in pain and it wasn’t working — that was the right decision for you and Priya. Formula feeding is a completely safe and appropriate way to feed a baby.”
  • Never imply that breastfeeding would have prevented CMPA (it would not have — breastfed infants get CMPA too; they just need maternal dairy-free diet instead)
GP safeguarding and wellbeing actions: administer EPDS at this consultation; ask directly about sleep; ask about home support; enquire about domestic violence (using validated opportunistic enquiry); observe parent–infant interaction; if concern about NAI: follow safeguarding pathway; brief Mrs. Sharma on safe handling of a crying infant (purple crying) — not to add to her anxiety, but as standard information for all parents of crying infants in this age group.
1C — PMH · Family history · Social history
🥐 Medical and family history
FactorWhy it mattersImpact
Family history of atopy (first-degree relatives)Atopy (asthma; eczema; hayfever; food allergy) in first-degree relatives is the strongest risk factor for CMPA. Priya: father has asthma; mother has hayfever — two affected first-degree relatives. Risk of CMPA in an infant with two affected first-degree relatives: approximately 40–60% vs 5–10% in the general population. The family atopy history also increases the probability that Priya’s CMPA is IgE-mediated (though non-IgE remains more common overall). It also predicts that Priya may develop other atopic conditions (eczema management important; asthma risk later).High atopy background: CMPA is the working diagnosis; eHF trial; allergy team referral for follow-up; eczema management alongside CMPA treatment; vigilance for IgE-mediated features
Birth history: gestation; delivery; early feedingPrematurity and early gut microbiome disruption increase CMPA risk. Formula feeding from birth (as in Priya who had early breastfeeding difficulties) presents more allergen load earlier. Priya was born at term; normal delivery; initially breastfed for 2 weeks — this is relevant because breastfeeding (even for 2 weeks) may have provided some passive immune protection but does not prevent CMPA in atopic infants. The switch to formula at 2 weeks followed by symptom onset at 3 weeks strongly supports CMPA as the cause.Term; normal delivery; breastfed 2 weeks; formula from 2 weeks: timeline supports CMPA diagnosis; no pre-existing diagnosis or specialist input
Eczema in Priya — distribution; severityAtopic dermatitis in an infant with GI symptoms: highly specific for CMPA. Mechanism: food allergy (particularly CMPA in infants) is a trigger for atopic dermatitis in 30–40% of infants with moderate-severe eczema. Priya has cheek eczema — typical distribution for infant atopic dermatitis. The coexistence of eczema and GI symptoms (reflux; green stools) in an atopic family almost clinches the CMPA diagnosis. Eczema management: emollient therapy (Diprobase; Epaderm) + topical hydrocortisone 1% for flares; CMPA treatment often reduces eczema severity over 2–4 weeks.Cheek eczema + GI symptoms + family atopy: CMPA the working diagnosis. Prescribe emollient + topical hydrocortisone 1% for eczema management alongside eHF. Eczema severity scoring (SCORAD; EASI) at each review
Previous formula tried; response to treatmentsPriya is on SMA First (standard cow’s milk-based formula). Two courses of Infant Gaviscon — no improvement. Response (or non-response) to treatment is a key diagnostic tool: failure of Gaviscon (an alginate that treats reflux mechanically) while atopic and growth-faltering tells us this is not simple GOR but CMPA. The GP who prescribes a third course of Gaviscon — or switches to SMA Comfort (a partially hydrolysed formula with different curd structure, not sufficient for CMPA) — is missing the diagnosis. The appropriate next step is eHF.SMA First → eHF (Nutramigen 1 with LGG; Aptamil Pepti 1; SMA Althera). Do NOT switch to HA formula (SMA HA; Aptamil Comfort) — not sufficiently hydrolysed for CMPA. Do NOT switch to goat’s milk formula (major cross-reactivity).
🏠 Social and feeding history
FactorWhy it mattersImpact
Breastfeeding history and cessationMrs. Sharma stopped breastfeeding at 2 weeks due to latching difficulties and mastitis. This is a significant piece of history for two reasons: (1) clinically: if she were still breastfeeding, the management would be maternal dairy-free diet (not formula change); the history of breastfeeding cessation at 2 weeks and symptom onset at 3 weeks strongly implicates the formula introduction; (2) psychologically: Mrs. Sharma is likely carrying guilt about this. Direct address is important: “stopping breastfeeding when you were in pain with mastitis was the right decision for you and Priya”.Formula-fed: intervention is eHF formula change (not maternal dairy-free diet). Breastfeeding guilt: address directly and compassionately. If she were still breastfeeding: maternal dairy-free diet for 2–4 weeks (infant continues breastfeeding).
Sleep; support; Mrs. Sharma’s wellbeingMrs. Sharma is sleeping 4–5 hours of broken sleep per night for 4 months. This level of sleep deprivation has significant effects on cognitive function; emotional regulation; and parenting capacity. She may be minimising how much she is struggling — asking directly: “How are you coping with all of this? Is there anyone helping you at night?” Postnatal depression is a real risk. EPDS should be administered. Health visitor support; community midwife; GP support — the infant’s wellness and the mother’s wellness are inseparable.EPDS at this consultation. If EPDS ≥13: PND management (sertraline; CBT; NHS Talking Therapies referral). Sleep advice; night feed support (partner; family). Social prescribing: parent–infant groups; NCT network; health visitor home visits.
Partner support; cultural contextMr. Sharma’s atopy is relevant (asthma: confirmed first-degree relative). Is he helping with night feeds and daytime care? Cultural attitudes to formula feeding; illness in babies; medical help-seeking can affect how Mrs. Sharma interprets information and whether she implements advice. Dietary preferences: is the family vegetarian or vegan? This is relevant for eHF formula choices — some families object to bovine-derived hydrolysed formulas on dietary grounds; amino acid formulas may be more acceptable to some families; paediatric dietitian input is valuable here.Partner support assessed. Cultural dietary preferences (vegetarian/vegan): AAF may be preferable for some families (soy-free amino acid formula). Dietitian referral for families with complex dietary preferences. EPDS considers cultural expression of depression.
Feeding technique and feed volumeInadequate formula volume is a common and easily missed cause of poor weight gain in formula-fed infants. Recommended formula intake: approximately 150–200 ml/kg/day. For Priya (4.2 kg): approximately 630–840 ml/day. Also: feeding technique — is formula being prepared correctly (one level scoop per 30 ml water; not over- or under-concentrated)? Vomiting after feeds: does Priya vomit 1–2 times per feed (likely); this affects net volume intake. Feed volume inadequacy may coexist with CMPA.Calculate expected feed volume (150–200 ml/kg/day); check current intake; if inadequate: address this alongside eHF; confirm formula preparation technique; consider feeding diary.
1D — ICE
💡 Ideas
"What do you think is causing Priya’s symptoms? Have you had any thoughts about what might be going on?"
Mrs. Sharma has been researching for 4 months. She likely has a theory — possibly that Priya has CMPA, which she has found online. Understanding her illness model allows the GP to build on what she knows rather than contradicting her. If she has correctly self-diagnosed CMPA: “you are absolutely right — and that is exactly what I think is happening too. Let me explain what that means and what we can do about it.” If she thinks it is reflux requiring Gaviscon or omeprazole: the GP can gently redirect without dismissing previous management.
😟 Concerns
"What worries you most about what is happening? Is there anything you are frightened this might be?"
Mrs. Sharma’s concerns are likely: (1) that something serious and hidden is wrong with Priya (biliary atresia; pyloric stenosis; serious disease — these have been a concern because symptoms persist despite treatment); (2) that she has caused the problem by stopping breastfeeding; (3) that she is being judged for not managing this better. Each of these must be directly addressed. The concern about breastfeeding guilt is particularly important — it is not going to be raised unless the GP creates space for it.
🎯 Expectations
"What would you most like to come out of today’s appointment? What would feel like it had helped?"
Mrs. Sharma probably wants: an explanation of why Priya has been suffering; a specific, actionable plan that is different from what has not worked; reassurance that nothing serious is being missed; and acknowledgement that she has been doing her best. The GP who addresses all four of these directly — "here is what is happening; here is the plan; here is why I am confident nothing sinister is going on; and I can see how hard you have been working" — will leave Mrs. Sharma feeling genuinely supported rather than just processed.
1E — Psychosocial context: maternal exhaustion and infant distress
🧑‍🏫 The wellbeing of the parent and the wellbeing of the infant are inseparable in this consultation

Priya has been in discomfort for 4 months. Mrs. Sharma has been exhausted, anxious, and guilty for the same period. The GP who only assesses Priya and ignores Mrs. Sharma’s wellbeing is providing incomplete care. A mother with postnatal depression, social isolation, and inadequate sleep cannot effectively implement complex feeding changes — practical support for Mrs. Sharma is therefore also treatment for Priya.

😱 Maternal Guilt (Breastfeeding)

Stopping breastfeeding at 2 weeks due to mastitis and latching difficulties is associated with significant maternal guilt, particularly in first-time mothers. This guilt can interfere with the therapeutic relationship if unaddressed. The GP who says “you did the right thing; breastfeeding when you are in pain and struggling is not good for either of you; formula feeding is a completely safe option” removes a significant psychological barrier.

"You stopped breastfeeding because you were in pain and you weren’t getting the support you needed. That was the right decision for you and for Priya at that time. It is not the cause of what is happening now — babies with atopic backgrounds get CMPA whether they are breastfed or not."
😴 Sleep Deprivation and Exhaustion

Four months of 4–5 hours broken sleep is a form of significant physical and psychological stress. It is associated with: impaired cognitive function (difficulty processing medical information; remembering instructions); emotional dysregulation; increased PND risk; reduced parenting capacity. Practical support is more important than information at this point: EPDS; health visitor involvement; social support. The formula change plan must be simple enough to implement by someone running on very little sleep.

"I want to ask about you as well. You have not been sleeping. That is really hard. Is there anyone helping you with night feeds? Your husband? Family? I want to make sure you have some support, not just for Priya but for yourself."
🖥️ Internet Self-Diagnosis and Anxiety

Mrs. Sharma has been researching for 4 months and may have arrived at CMPA as her own diagnosis. This is often more helpful than harmful — an informed parent who has done research is a parent who is engaged and motivated. The GP’s role is to validate the research, confirm or redirect the diagnosis, and fill in the gaps with clinical reasoning. Never dismiss parental internet research: “You are right — and what you found online is consistent with what I am seeing.”

"You’ve clearly been doing a lot of research. What have you found? I want to understand what you are thinking so we can work through it together."
💔 Emotional Cost of a Crying Infant

A persistently crying infant at 3–5 months of age is one of the highest-risk periods for non-accidental injury (shaken baby syndrome). Mrs. Sharma needs to know this is not because the GP suspects her — but because every parent needs information about what to do when a baby will not stop crying (purple crying; safe handling; putting the baby down safely and stepping away). This information is delivered with care and as part of standard parenting support, not as a safeguarding accusation.

"One more thing I want to mention — I ask this with all parents of babies who have been crying a lot: when it gets very hard and Priya won’t stop crying, have you heard of putting her down safely in her cot and stepping away for a few minutes? Sometimes that is the safest thing to do. I know you would never hurt her — but knowing this helps."
🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills
Key phrases that score
"Before we go through everything, I just want to say — four months of a baby who is crying and not settling is really tough. You are clearly doing everything right."
"When did Priya start formula? And when exactly did the symptoms start? I want to understand the timing." [This is the most diagnostically important question in CMPA — temporal relationship between cow’s milk introduction and symptom onset]
"Has she ever had any sudden reactions after a feed — any swelling; hives; difficulty breathing? I’m asking because there is a different type of allergy where the reaction is immediate, and that would change what we do completely." [IgE vs non-IgE screening question]
Deductions
  • Not asking about timing of formula introduction vs symptom onset — the temporal relationship is the cornerstone of the CMPA clinical diagnosis
  • Not asking about immediate IgE-mediated features (urticaria; swelling; wheeze — within 2 hours) — missing IgE-mediated CMPA is a significant SCA fail
  • Not addressing breastfeeding guilt if Mrs. Sharma mentions it — a missed Relating to Others opportunity that affects the whole consultation
🔴 Red
No maternal acknowledgement; timing of formula not explored; IgE vs non-IgE not distinguished; breastfeeding guilt unaddressed; Gaviscon prescribed for third time without reassessment
🟠 Amber
Empathetic opener; timing explored; CMPA recognised; IgE features not specifically asked about; eHF formula plan discussed; EPDS not administered; breastfeeding guilt not addressed
🟩 Green
Maternal acknowledgement; timing of milk introduction vs symptoms; IgE features specifically excluded; eczema + family atopy + green stools + growth faltering = CMPA working diagnosis; eHF plan; breastfeeding guilt addressed; EPDS administered; purple crying information; clear 2–4 week review plan
2
Step 2
Triage — Anaphylaxis / Acute IgE · Urgent CMPA · Routine Non-IgE-Mediated CMPA
collapse
CMPA triage is primarily about distinguishing acute IgE-mediated anaphylaxis (999) from urgent non-IgE-mediated CMPA with growth faltering (urgent review) from routine GP-managed non-IgE-mediated CMPA. Priya is in the urgent category: faltering growth + atopy + non-response to Gaviscon.
🔴 Emergency

999 or A&E Now

Immediate escalation
  • Anaphylaxis — urticaria + wheeze + collapse within 2 hours of feedAdrenaline (EpiPen Junior 150 mcg); 999; AAF not eHF; urgent allergy referral
  • Bilious vomitingIntestinal obstruction until proven otherwise; surgical emergency; 999 or A&E
  • Apnoea or cyanosis during feedAspiration; cardiac; neurological; 999
  • Pale/acholic (white) stoolsBiliary atresia; same-day surgical referral
  • Faltering growth ≥2 centile crossingsUrgent same-day paediatric referral
🟠 Urgent — Priya today

eHF + Review in 2–4 Weeks

Urgent GP management
  • Non-IgE-mediated CMPA + 1 centile drop (Priya)eHF formula change; dietitian referral; allergy team referral; 2–4 week review
  • Eczema + atopy + green stools + Gaviscon failureStrong CMPA probability; eHF; EPDS for mother; health visitor alert
🟩 Routine

GP-Managed

4-week eHF trial
  • Mild non-IgE-mediated CMPA; no growth faltering; no eczemaeHF formula; 4-week trial; review
  • Simple physiological GOR (happy spitter — good growth; no atopy)Reassurance; thickened feeds or Gaviscon if distressing; 6-month review
🎓 SCA Checkpoint — Step 2Tasks
Triage for Priya
"The good news is that nothing about what you are describing sounds immediately dangerous — no bilious vomiting; no episodes where Priya went blue or stopped breathing; her stools are green but not bloody. What I am seeing is a pattern that I think is caused by an allergy to cow’s milk protein — and the good news about that is that it is something we can address with a formula change today."
Deductions
  • Prescribing Gaviscon again without reassessing — Gaviscon has been tried twice and failed; repeating the same intervention without reassessment is not appropriate management at this stage
3
Step 3
Examination — Weight & Centile · Skin · Abdomen · Hydration
collapse
The examination in suspected CMPA confirms the clinical picture and identifies severity markers that determine management urgency. Weight and centile plotting are the single most important objective finding.
ExaminationWhat to findFinding changes managementChanges?
Weight — plot on centile chart (RCPCH 0–4 chart)Weigh naked or in nappy only; compare to birth weight and previous measurements; plot and join to create trajectoryWeight and centile trajectory is the most important objective finding in an infant presenting with feeding difficulties. Priya: born 3.8 kg (50th centile); now 4.2 kg at 4 months (25th centile). A drop from 50th to 25th centile represents approximately 1 centile crossing. RCPCH guidance: 1 centile crossing warrants monitoring and investigation; 2 centile crossings = cause for concern; 3 centile crossings = urgent referral. Priya’s 1-centile drop combined with the clinical picture (CMPA) warrants: eHF change today; review in 2–4 weeks; dietitian referral; if not improving: paediatric referral. Plot weight, length (if possible), and head circumference — failure to thrive across all three parameters suggests a systemic cause; failure of weight only suggests caloric cause (CMPA; inadequate intake).1 centile drop + CMPA: eHF change; 2–4 week review; dietitian. 2 centile drop: paediatric referral urgently. Weight tracking well: reassurance; milder intervention.YES — centile trajectory determines urgency of referral and follow-up
Skin — eczema distribution; severity scoring (SCORAD)Check face (cheeks; scalp); neck folds; elbow and knee flexures; wrists and ankles; severity: mild/moderate/severeAtopic dermatitis in Priya: cheek eczema. Cheeks are the typical distribution for infant eczema — they are the skin in most contact with formula during dribbling and around the mouth. Severity affects management: mild eczema (emollient + topical hydrocortisone 1% for flares; CMPA treatment will often help); moderate-severe eczema (topical corticosteroid; CMPA urgent treatment; consider SALT/dermatology referral). Document SCORAD or IGA score at baseline — this allows comparison after eHF trial to confirm that the eczema improves with milk elimination (additional evidence for CMPA). If eczema is severe or extensive: consider paediatric dermatology referral alongside CMPA management.Mild eczema (Priya): emollient + HC 1% for flares; eHF. Moderate eczema: stronger topical CS (HC 2.5% or betamethasone 0.025% face); dermatology referral. Severe: urgent dermatology.YES — eczema severity determines topical treatment and referral urgency
Abdominal examination — distension; tenderness; masses; bowel soundsAbdominal examination in suspected CMPA: usually unremarkable in non-IgE-mediated CMPA. However: abdominal distension may indicate bowel gas accumulation (from colic and altered gut motility in CMPA); significant tenderness on palpation warrants investigation for other diagnoses (intussusception; appendicitis — less relevant in a 4-month-old but generalised peritonitis always possible). Palpable mass (right lower quadrant in older infant): intussusception. Absent bowel sounds: ileus. Priya’s examination: soft; non-tender; no masses; bowel sounds present — reassuring.Distension only: consistent with CMPA; colic. Tenderness + distension: consider obstruction; intussusception — A&E. Mass: A&E. Normal: proceed with eHF trial.Context — reassuring exam supports conservative CMPA management
General appearance — hydration; muscle wasting; fontanelle; interaction
Well or unwell? Sunken fontanelle? Poor skin turgor? Interaction with mother?
General well/unwell assessment: is Priya well-appearing (alert; responsive; pink) or unwell-appearing (listless; pale; sunken fontanelle; reduced interaction)? An unwell-appearing infant with CMPA needs urgent hospital assessment — she may be dehydrated from vomiting and diarrhoea; or have a concurrent infection that has unmasked the severity. Priya: alert; interacting with mother — reassuring. Signs of dehydration (sunken fontanelle; reduced skin turgor; dry mouth; reduced nappy output): require immediate oral rehydration or hospital IV fluids before proceeding with CMPA management.Well-appearing (Priya): proceed with eHF change; community management. Signs of dehydration: oral rehydration solution (Dioralyte; diluted formula not appropriate); if not tolerating: hospital. Unwell: A&E.YES — unwell appearance changes urgency
🎓 SCA Checkpoint — Step 3Tasks
Weight plotting
"I want to weigh Priya today and plot it on her growth chart. The most important thing I can check is whether she is growing as we would expect. Can you take off her clothes and nappy?"
Deductions
  • Not weighing Priya and plotting on centile chart — weight trajectory is both a severity marker and a key diagnostic criterion; managing a feeding problem without plotting weight is a significant omission
4
Step 4
Investigations — Centile Plotting · No Allergy Test for Non-IgE · IgE Testing if Indicated
collapse
The key investigation principle in non-IgE-mediated CMPA: there is no reliable diagnostic allergy test. Skin prick tests and specific IgE are NEGATIVE in non-IgE-mediated CMPA (by definition — no IgE antibody is involved). Ordering allergy tests for non-IgE-mediated CMPA causes false reassurance (negative test does not rule out CMPA) and unnecessary needle procedures for the infant. The correct “investigation” is the clinical elimination trial.
InvestigationWhen indicatedResult interpretation
Centile chart plottingEssential: plot all available weight measurements + today’s weight; track trajectoryPlotting the centile chart is not an investigation in the traditional sense — but it is the most important clinical measurement in this consultation. It converts the subjective "she doesn’t seem to be growing" into an objective, standardised severity marker. Priya: 50th centile at birth; 25th centile at 4 months — one centile crossing. This is the objective severity criterion that determines management urgency and follow-up timeline. Growth charts must be used: RCPCH UK-WHO charts (2–18 years) and 0–4 year charts for infants.No centile drop: GOR probable; eHF trial appropriate but not urgent; 4-week review. 1 centile drop (Priya): CMPA urgent; eHF; dietitian; 2-week review. 2 centile drop: paediatric referral same day. 3 centile drop: hospital admission.
Specific IgE (CAP/RAST) for cow’s milk; skin prick testONLY if IgE-mediated features are present (immediate reaction <2 hours; urticaria; angioedema; wheeze)Allergy testing (specific IgE or skin prick test) is indicated when IgE-mediated CMPA is suspected. This means: immediate reactions (<2 hours of milk ingestion); urticaria; angioedema; wheeze; any anaphylaxis features. Priya’s presentation: delayed symptoms; green stools; eczema — this is non-IgE-mediated; allergy testing would be NEGATIVE and therefore misleading. Ordering allergy tests for a non-IgE-mediated presentation: (a) will return a negative result; (b) causes false reassurance (“the allergy test was negative so it’s not an allergy”); (c) subjects the infant to unnecessary bloods. In non-IgE-mediated CMPA: do NOT order allergy tests. The diagnosis is clinical.IgE-mediated CMPA (immediate reaction): SPT or specific IgE indicated — refer to allergy team or community CMPA nurse; result guides: AAF vs eHF; EpiPen decision; rechallenge protocol. Non-IgE-mediated (Priya): NO allergy test — clinical diagnosis + elimination trial.
Stool culture and microscopyIf bloody stools; diarrhoea with fever; in younger infant (<8 weeks) with any GI symptomsStool examination is not routine in CMPA but is indicated if: bloody stools (CMPA colitis vs infective colitis vs intussusception); significant diarrhoea with fever (sepsis; viral gastroenteritis); symptoms in an infant under 8 weeks (sepsis must be excluded first). Priya: green watery stools but NO blood; NO fever — stool culture not indicated. If stool culture were indicated: check for pathogenic bacteria (Salmonella; Campylobacter; E. coli O157); parasites (Giardia); if rotavirus suspected in a vaccinated area: rotavirus antigen test.No blood; no fever (Priya): stool culture not indicated. Blood in stools: stool culture; urgent paediatric referral (CMPA colitis vs infective colitis). Fever + diarrhoea: stool culture; consider sepsis workup if systemically unwell.
EPDS (Edinburgh Postnatal Depression Scale) — for Mrs. Sharma10-item questionnaire; scored in GP surgery; takes 2–3 minutesWhile EPDS is technically a screening tool rather than an investigation, it is a clinical assessment that must be completed at this consultation. Mrs. Sharma: sleeping 4–5 hours broken sleep; persistent anxiety about Priya’s health; guilt about breastfeeding; first-time mother — multiple PND risk factors. EPDS score ≥13: probable PND; management includes sertraline (safe in breastfeeding and post-partum); CBT; NHS Talking Therapies referral; health visitor intensive support. EPDS score on Q10 (self-harm) ≥1: urgent psychiatric referral regardless of total score. Complete the EPDS before Mrs. Sharma leaves today.EPDS <10: normal; monitor. EPDS 10–12: borderline; watchful waiting; health visitor; GP review in 2 weeks. EPDS ≥13: PND; treatment (sertraline; NHS Talking Therapies; HV). Q10 ≥1: urgent psychiatric referral regardless of total score.
🎓 SCA Checkpoint — Step 4Tasks
Investigations communication
"I do not need to do blood tests for this type of allergy — and I want to explain why, because I know it might seem surprising. The type of allergy I think Priya has is called non-IgE-mediated — that means the blood test for allergy would come back negative, even if she does have the allergy. The way we confirm the diagnosis is by changing her formula and seeing if she gets better. That is the test."
Deductions
  • Ordering specific IgE or skin prick test for a presentation consistent with non-IgE-mediated CMPA — will return negative; causes false reassurance; inappropriate investigation for this clinical picture
5
Step 5
Diagnosis — CMPA vs GOR vs GORD · Plain Language · IgE vs Non-IgE
collapse
The clinical diagnosis of non-IgE-mediated CMPA rests on the combination of symptom timing; atopic features; feeding history; and response to elimination — not on allergy testing. For Mrs. Sharma, this must be explained in plain language that acknowledges the health visitor’s previous advice without undermining it.
🗣️ Explaining CMPA in plain language

"What I think is happening with Priya is something called cow’s milk protein allergy. The protein in standard formula is from cow’s milk — and Priya’s immune system is reacting to it. It’s not that the formula is bad — it’s that her immune system is treating the cow’s milk protein as if it’s an invader and reacting against it. That reaction causes the inflammation in her gut which is causing the green stools; the vomiting; and the discomfort. It also explains the skin rash on her cheeks. This is quite common in babies — about 2 in 100 have it — and the great news is that most children grow out of it completely by the time they are three to five years old."

💬 Addressing Mrs. Sharma’s questions

"The health visitor said it was reflux — was she wrong?"
"The health visitor wasn’t wrong to start there — what Priya has does look like reflux, and Gaviscon was a completely appropriate first step. But Gaviscon treats the reflux mechanically, by thickening the stomach contents. If the underlying problem is an allergy — which I now think it is — Gaviscon can’t help with that part. That’s why it has not been working. What we need now is a formula that doesn’t contain the protein that Priya is reacting to."

"Did stopping breastfeeding cause this?"
"No. Breastfed babies can get cow’s milk protein allergy too — it just comes through the mother’s milk if the mother is eating dairy. Stopping breastfeeding did not cause this. What matters now is what we do from here — and that is something we can fix."

Priya’s presentation — Non-IgE-mediated CMPA
Working diagnosis — clinical
Delayed symptoms (3 weeks, 1 week after formula); green watery stools; eczema; family atopy (father asthma; mother hayfever); faltering growth (50th → 25th centile); failed Gaviscon ×2. No immediate reactions; no urticaria; no angioedema — non-IgE-mediated. Management: eHF formula; 2–4 week trial; review.
Physiological GOR (“happy spitter”)
Reassurance + thickened feeds

Good weight gain; no atopy; not distressed

70% of infants at 4 months; peaks at 4 months; resolves by 12–18 months. No eczema; no family atopy; weight tracking well; normal stools. Management: parental reassurance; positioning; thickened feeds or Gaviscon if concerning parents.

IgE-Mediated CMPA / GORD with Complications
Urgent referral

Immediate reactions (<2h); anaphylaxis; or 2× centile drop

IgE-mediated: urgent allergy referral; SPT or specific IgE; EpiPen; AAF (not eHF until tested). GORD with 2× centile drop: urgent paediatric referral; PPI may be appropriate; endoscopy if severe.

📊 CMPA classification — IgE vs non-IgE
FeatureNon-IgE-mediated (Priya)IgE-mediatedClinical significance
Timing of reactionDelayed: 2–72 hours after milk ingestionImmediate: within 2 hoursKey distinguishing feature; determines allergy testing and management
Allergy testSPT and specific IgE NEGATIVE — do NOT orderSPT or specific IgE POSITIVENon-IgE: diagnosis is clinical; ordering tests causes false reassurance
First-line formulaeHF (Nutramigen; Aptamil Pepti)AAF (Neocate; Alfamino) until allergy testing confirms eHF toleranceUsing HA/partially hydrolysed formula is WRONG for both types
Anaphylaxis riskNoYes — EpiPen; written allergy action planEpiPen ONLY for IgE-mediated with anaphylaxis history or risk
Resolution60% by age 2; 80% by age 3; 90% by age 5Variable; may persist longer; often with other atopic conditionsPrognosis is reassuring for non-IgE-mediated; give this message to Mrs. Sharma
🎓 SCA Checkpoint — Step 5TasksRelating to Others
Diagnosis in plain language
"What I think is happening is that Priya’s immune system is reacting to the protein in standard formula — it’s called cow’s milk protein allergy. This is not caused by anything you did or didn’t do. The Gaviscon was a sensible first step — it just treats a different part of the problem. What Priya needs is a formula where the protein has been broken down so much that her immune system doesn’t recognise it. Most children with this type of allergy grow out of it completely by the age of three or four."
Deductions
  • Blaming the health visitor or implying that previous management was wrong — Gaviscon was appropriate as a first step; the clinical picture has evolved; undermining the health visitor damages the parent’s relationship with other healthcare professionals
6
Step 6
Referral — Paediatric Allergy · Dietitian · Paediatric Gastroenterology
collapse
Non-IgE-mediated CMPA with 1 centile drop: urgent dietitian referral (milk ladder planning; weaning advice) and allergy team referral for review. IgE-mediated: urgent allergy team today. Paediatric gastroenterology if GORD with complications or complex differential.
ReferralUrgencyWhat GP doesWhat NOT to do
Paediatric Allergy Team (or CMPA clinical nurse specialist where available)Routine — 4–6 weeks for non-IgE-mediated. Urgent if IgE-mediated (within 2 weeks)Refer to paediatric allergy team for: (1) formal CMPA diagnosis confirmation; (2) milk ladder guidance (supervised reintroduction); (3) weaning advice (which foods to introduce first, which to delay); (4) DEXA risk assessment for future bone health; (5) co-existing atopy management. Include in referral: feeding method; formula history; symptoms (onset; character; severity); atopy history; family atopy; weight trajectory; response to interventions. Most GP-managed non-IgE-mediated CMPA improves on eHF without allergy team — but Priya has faltering growth and eczema, which warrant referral.Do NOT delay referral because the infant is “improving a bit” — allergy team is needed for milk ladder guidance, which parents cannot safely navigate alone. Do NOT progress the milk ladder without allergy team input for IgE-mediated CMPA — anaphylaxis risk on rechallenge.
Paediatric DietitianRoutine — 4 weeks; urgent if faltering growth ≥2 centile dropsPaediatric dietitian referral for Priya: (1) confirm appropriate eHF formula and volume for age and weight; (2) weaning planning (CMPA infants need careful introduction of dairy-containing solids at 6 months via milk ladder); (3) calcium intake calculation and supplementation if needed; (4) maternal calcium and vitamin D supplementation for any concurrent dairy-free breastfeeding. Also: assess whether formula volume and preparation technique are correct — insufficient formula intake is a common co-existing cause of poor weight gain.Do NOT advise parents to progress the milk ladder themselves without dietitian support — incorrect milk ladder progression can lead to anaphylaxis in IgE-mediated cases and symptom recurrence in non-IgE-mediated. Do NOT assume the family knows which foods contain hidden milk — dietitian provides a comprehensive list of dairy-containing foods to avoid during the exclusion trial.
Health Visitor — alert about CMPA diagnosis and maternal wellbeingSame-day communicationAlert the health visitor today: (1) CMPA diagnosis; formula change to eHF; 2–4 week review plan; (2) Mrs. Sharma’s EPDS result and any mental health concerns; (3) request for increased health visitor contact during the transition period (weekly home visits can support the formula change and Mrs. Sharma’s wellbeing). The health visitor and GP work in partnership — sharing the CMPA diagnosis allows the health visitor to support Mrs. Sharma practically (formula preparation; feeding diary; centile monitoring).Do NOT treat CMPA in isolation from the community team — Mrs. Sharma needs coordinated support from GP; health visitor; and dietitian. An isolated GP prescription of eHF without community follow-up is likely to fail.
Paediatric GastroenterologyUrgent if: GORD with complications; 2‗ centile drop; eHF not helping after 4 weeksPaediatric gastroenterology referral is NOT needed for routine non-IgE-mediated CMPA. It IS needed if: (1) GORD with complications (aspiration; ≥2 centile drops; haematemesis); (2) failure to respond to eHF after 4 weeks (consider AAF; other food allergy; alternative diagnosis); (3) complex differential (biliary atresia; pyloric stenosis if not already excluded; malabsorption). Do NOT routinely refer all CMPA — this creates unnecessary waiting time and parental anxiety. The majority of non-IgE-mediated CMPA is managed successfully in primary care with allergy team and dietitian support.Do NOT refer for endoscopy or pH-metry in simple CMPA without indications — invasive investigations are not required; diagnosis is clinical. Do NOT delay referral when complications are present (aspiration; severe growth faltering; haematemesis).
🎓 SCA Checkpoint — Step 6Tasks
Referral communication
"I am going to refer Priya to a dietitian — they are the experts in making sure she gets the right nutrition as she grows, and they will help plan when to introduce milk back in gradually as she gets older. I will also refer to the allergy team to make sure we have proper support going forward. And I am going to let your health visitor know what we have decided today so that she can check in on you both."
Deductions
  • Not referring to a paediatric dietitian for a child with CMPA and faltering growth — dietitian is essential for milk ladder guidance and weaning planning; this is not optional in a child who has dropped a centile
7
Step 7
Management — eHF Formula · Gaviscon · Omeprazole Criteria · Eczema · Milk Ladder · Maternal Wellbeing
collapse
7A — Address Mrs. Sharma’s expectations
🤝
Mrs. Sharma came expecting either more Gaviscon or omeprazole — and probably came hoping the GP would solve a 4-month problem today
1
Validate what has already been tried

Gaviscon was not a wrong treatment — it was the right first step for what looked like reflux. The clinical picture has evolved. The GP who validates previous management — including the health visitor’s advice — maintains Mrs. Sharma’s trust in the healthcare system and avoids undermining the health visitor.

"The Gaviscon was exactly the right thing to try first. It was a completely appropriate step — it just treats the reflux mechanically, and if the underlying problem is an allergy, it can’t fix that part. Now we know more, we can target what is actually causing the problem."
2
Explain why this is different from what has been tried

Mrs. Sharma needs to understand why this formula change is different from any previous attempt — otherwise she may not implement it, or may mix eHF with standard formula, or may not persist for the full 2–4 weeks. The key concept: the new formula has been broken down to the point where Priya’s immune system does not recognise it.

"The formula I am going to prescribe — it is called an extensively hydrolysed formula — has the cow’s milk protein broken down into tiny fragments that Priya’s immune system will not react to. It is not a standard formula and it is not a comfort formula — it is a medical formula prescribed specifically for this problem."
3
Give a clear timeline and a specific review

Mrs. Sharma has been managing uncertainty for 4 months. A specific timeline and a booked review appointment provide the predictability and hope that she needs. The 2–4 week timeline is achievable; the review appointment makes the plan concrete.

"Most babies start to improve within 1–2 weeks of the formula change. By the end of 4 weeks, if Priya has improved, we will know that cow’s milk was the problem. I want to see you both back in 2 weeks — I am going to book that appointment now so it is in the diary."
7B — Treatment goals
Goals for Priya
Symptom resolution: reduced crying; less vomiting; formed stools within 2–4 weeks of eHFWeight gain recovery: tracking centile within 2 months of eHF; dietitian monitoring Eczema improvement: emollient twice daily; topical HC 1% for flares; reassess SCORAD at reviewControlled milk reintroduction: milk ladder via dietitian from 6–12 months Normal development and nutrition: adequate formula volume; vitamin D supplementationComplete tolerance of milk products by age 3–5 (90% of non-IgE CMPA) Mrs. Sharma: EPDS followed up; sleep support; health visitor contact; guilt addressed2-week GP review booked before Mrs. Sharma leaves today
Motivational language for Mrs. Sharma
"The reason I feel confident about this diagnosis is the combination of the timing — symptoms starting one week after the formula started — the eczema, the family history, the green stools, and the fact that Gaviscon has not helped. When everything points in one direction, that is a strong clinical picture."
"And here is the really good news: 90% of children with this type of allergy grow out of it completely by the time they are five. Priya is going to be absolutely fine."
7C — Non-medication management and formula technique
🥙
eHF Formula Technique
100% replacement of SMA First; no mixing; full switch day 1
Why full switch

The eHF must completely replace standard formula from day 1 of the trial. Any residual standard formula in the feeding regimen (e.g. mixing one bottle per day; using SMA First for night feeds because eHF is more expensive) will prevent symptom resolution and invalidate the trial. Mrs. Sharma must be told: complete replacement from today. If she cannot afford the eHF formula: it should be prescribed on FP10 (GP prescription) — NHS prescription for approved CMPA management. All eHF formulas are prescribable in primary care.

Practical

Prescribed eHF: Nutramigen 1 with LGG; Aptamil Pepti 1; SMA Althera (birth to 6 months). 150–200 ml/kg/day as with standard formula. The formula may smell different (characteristic hydrolysed smell); this is normal and does not indicate it is spoiled. Some infants initially refuse eHF — introduce gradually over 1–2 days if needed (e.g. start with 80% eHF: 20% standard; increase to 100% over 2–3 days). Check formula preparation technique (one level scoop per 30 ml water; correctly made up).

Full eHF switch from day 1: most infants show improvement in 1–2 weeks; full improvement in 2–4 weeks
🥂
Positioning and Feed Technique
Upright 20–30 minutes post-feed; smaller more frequent feeds
Evidence

Positioning after feeds reduces GOR by reducing the time oesophageal contents are in contact with the oesophagus in the lying position. Evidence for upright positioning is modest but widely recommended. Smaller more frequent feeds reduce the volume of gastric contents at any one time. Relevant for Priya even after eHF switch — reflux may take a few weeks to resolve completely even after formula change because gut inflammation takes time to heal.

Practical

After feeds: upright (held against shoulder; bouncy chair at 30-degree incline) for 20–30 minutes. Winding mid-feed and after feed. Smaller volumes more frequently if vomiting large amounts after feeds. Sleep position: back to sleep (supine) — always; never prone sleeping. Car seat should not be used for prolonged post-feed positioning.

Positioning reduces reflux frequency; important to continue even after eHF switch while gut heals
🤣
Eczema Management
Emollient twice daily; topical HC 1% for active eczema flares
Why alongside CMPA management

Priya’s eczema is both a marker of CMPA (atopic inflammation driven by milk allergy) and a separate problem requiring treatment. Emollient therapy: Diprobase; Epaderm; Hydromol — applied liberally twice daily to all skin (not just affected areas); emollient repairs the skin barrier disrupted by atopic inflammation. Topical hydrocortisone 1% (face-safe; weakest topical corticosteroid): applied to active eczema areas for 5–7 days; then stop. Eczema will typically improve with eHF formula change as the underlying CMPA inflammation resolves — but acute eczema should be treated alongside.

Practical

Emollient: Diprobase cream; apply after bath and before feeds; use a spoon or spatula (not fingers directly into pot) to reduce contamination. Topical HC 1%: apply twice daily to red/inflamed areas; avoid eyes; avoid normal skin. NICE: step up to 2.5% HC if 1% fails; moderate-severe eczema: referral to paediatric dermatology.

Emollient + topical HC 1% for eczema: treat alongside CMPA; eczema will improve as CMPA resolves over 2–4 weeks
Vitamin D Supplementation
8.5–10 mcg (340–400 IU) vitamin D daily for all infants
NICE guidance

All infants in the UK are recommended vitamin D supplementation: 8.5–10 mcg (340–400 IU) daily from birth to 1 year (Healthy Start vitamin drops; or infant vitamin D drops). Formula-fed infants receiving >500 ml standard or eHF formula per day: formula is fortified with vitamin D and supplementation is not routinely needed. If taking <500 ml/day formula (possible with a vomiting infant): supplement. Breastfed infants: must supplement as breast milk is low in vitamin D. Check that Priya is receiving adequate vitamin D given her current reduced intake from vomiting.

Practical

Healthy Start vitamins (free for qualifying families). Alternatively: Abidec drops (contain vitamin D); Bio-D-mulsion drops. Check whether Mrs. Sharma is registered for Healthy Start scheme (entitled if in receipt of certain benefits or if pregnant/has a child under 4).

All UK infants need vitamin D; formula-fed infants taking <500 ml/day formula: supplement with 8.5–10 mcg daily
💕
Feeding Diary
Simple record: feeds; stools; symptoms; weight; eczema
Why

A simple feeding diary maintained by Mrs. Sharma allows the GP to objectively assess response to eHF at the 2-week review. Without a diary: it is difficult to distinguish “she seems better” from “she is definitely better”. The diary also helps Mrs. Sharma feel in control (she is actively participating in the investigation) and reduces anxiety by giving her something constructive to do. Format: simple chart with date; feeds (volume; time); stools (colour; consistency); symptoms (crying episodes; vomiting; eczema); weight when available.

Practical

Provide a template or direct to an app (NHS Start4Life; CMPA Support websites). At the 2-week review: review the diary together. Improvement in symptoms — particularly stool normalisation and reduction in crying — confirms eHF is working.

Feeding diary: empowers Mrs. Sharma; provides objective data for 2-week review; confirms eHF response
📍
Maternal Dairy-Free Diet (if breastfed)
Not applicable for Priya (formula-fed); essential if breastfed
Breastfed infants with CMPA

If Priya were breastfed: the management would be maternal dairy-free diet for 2–4 weeks — NOT formula change. The infant continues breastfeeding. Mother must avoid: all dairy (milk; cheese; yoghurt; butter; cream; any product with milk on the ingredient list). Calcium supplementation for the mother: 1000 mg/day (dairy is the primary dietary calcium source; must be replaced). Vitamin D: 10 mcg/day. Soy milk acceptable for the mother (but soy formula is NOT appropriate for the infant under 6 months). Most mothers find the dairy-free diet challenging — dietitian support is essential.

For Mrs. Sharma (formula-fed)

Not applicable for Priya. Explanation: “Because Priya is on formula, we change the formula. If you were still breastfeeding, I would ask you to cut out dairy from your own diet instead — but the principle is the same.” This explanation also addresses any lingering guilt about stopping breastfeeding — the management would have been different, but not necessarily easier.

Breastfed CMPA: maternal dairy-free diet 2–4 weeks + calcium + vitamin D; infant continues breastfeeding; do NOT switch to formula
7D — Prescribing guide
The first prescribing decision in CMPA is the formula choice — and the most common prescribing errors are: (1) prescribing HA/partially hydrolysed formula instead of eHF; (2) prescribing soy formula in an infant under 6 months; (3) prescribing goat’s milk formula (major cross-reactivity); (4) prescribing omeprazole without confirmed GORD with complications. For Priya: eHF from today; Infant Gaviscon can continue for ongoing reflux symptoms alongside eHF; omeprazole is NOT indicated; emollient + topical HC 1% for eczema.
Step 1 — eHF (non-IgE-mediated CMPA)
  • Nutramigen 1 with LGG; Aptamil Pepti 1; SMA Althera (birth to 6 months)
  • Complete replacement of standard formula from day 1; no mixing
  • Prescribable on FP10 (NHS prescription) — prescribe as a named product not generic
  • 150–200 ml/kg/day; same volume as standard formula
Review in 2–4 weeks; if improvement: confirm CMPA; continue eHF to 6 months; milk ladder via dietitian
Step 2 — AAF (IgE-mediated or eHF failure)
  • Neocate Infant; Alfamino; Nutramigen AA (amino acid formula)
  • For: IgE-mediated CMPA pending allergy testing; eHF failure after 4 weeks; severe non-IgE-mediated with multiple food allergies
  • NOT for routine non-IgE-mediated CMPA as first-line — eHF is less expensive and sufficient
  • Prescribable on FP10; typically initiated after allergy team review
Switch to AAF if eHF has been tried correctly for 4 weeks with no improvement; or if IgE-mediated CMPA is suspected
Step 3 — Do NOT use these formulas for CMPA
  • HA formula (SMA HA; Aptamil Comfort): partially hydrolysed; NOT sufficient for CMPA diagnosis or treatment; protein still antigenic enough to cause reactions
  • Goat’s milk formula: major cross-reactivity with cow’s milk (~90%); NOT safe for CMPA
  • Soy formula under 6 months: phytoestrogens; not recommended for infants under 6 months; 10–14% cross-react with soy anyway
  • Omeprazole: NOT for simple GOR or CMPA; only for confirmed GORD with complications
7E — Medication selector

Select infant characteristics — CMPA and reflux management guidance

CMPA and reflux management guidance
Breastfed infant with CMPA: maternal dairy-free diet for 2–4 weeks (infant continues breastfeeding; do NOT switch to formula); maternal calcium 1000mg/day + vitamin D 10 mcg/day; paediatric dietitian referral. Formula-fed non-IgE-mediated CMPA (Priya): eHF (Nutramigen 1 with LGG or Aptamil Pepti 1); complete switch from day 1; 150–200 ml/kg/day; review in 2–4 weeks; dietitian referral; allergy team. IgE-mediated (immediate reactions; urticaria; anaphylaxis): AAF immediately (not eHF until allergy tested); EpiPen Junior 150 mcg if anaphylaxis risk; URGENT allergy team referral (2 weeks); written allergy action plan; 999 if acute anaphylaxis. Reflux-dominant GOR (happy spitter; good growth; no atopy): reassurance; positioning; Infant Gaviscon if distressing. GORD with complications (faltering growth; aspiration): Infant Gaviscon first; omeprazole 0.7–1.4 mg/kg/day ONLY if confirmed GORD — not for simple GOR or CMPA. Eczema: emollient twice daily (Diprobase; Epaderm); topical HC 1% for active flares (face-safe); CMPA treatment will improve eczema over 2–4 weeks; SCORAD at baseline and review.
7F — Drug reference cards
Extensively Hydrolysed Formula (eHF)
Nutramigen 1 with LGG · Aptamil Pepti 1 · SMA Althera · Similac Alimentum · for birth to 6 months
✓ First-line formula for non-IgE-mediated CMPA — prescribable on FP10; complete switch from standard formula
Non-IgE-mediated CMPA in formula-fed infants: first-line (NOT HA formula)150–200 ml/kg/day; same volume calculation as standard formula; complete replacement from day 1
✓ When and how to prescribe
eHF is the MAP guideline and the iMAP guideline first-line formula for non-IgE-mediated CMPA in formula-fed infants. Mechanism: cow’s milk protein is broken into peptides short enough that the infant’s immune system does not recognise them as the original allergenic protein. Choice of product: Nutramigen 1 with LGG (contains probiotic Lactobacillus rhamnosus GG — some evidence for accelerating immune tolerance); Aptamil Pepti 1; SMA Althera. All are prescribable on FP10 and should be prescribed as a named product. Complete switch from day 1: do not mix with standard formula. Some infants initially refuse eHF (different taste and smell) — gradual introduction over 1–2 days with 80% eHF: 20% standard increasing to 100% over 2–3 days is acceptable. Volume: same as standard formula (150–200 ml/kg/day). Duration: until milk ladder reintroduction via dietitian (typically at 6–12 months).
✗ Wrong formulas — do not use for CMPA
HA formula (SMA HA; Aptamil Comfort; Cow & Gate Comfort): partially hydrolysed; still contains allergenic peptides; NOT appropriate for CMPA diagnosis or treatment. Many GP prescribing errors involve these formulas — they are marketed for “digestive comfort” but do not treat CMPA. Goat’s milk formula: approximately 90% cross-reactivity with cow’s milk; absolutely NOT appropriate for CMPA. Soy formula under 6 months: phytoestrogen content; not recommended by ESPGHAN or NICE for infants under 6 months; 10–14% of CMPA also react to soy.
⚠ Practical considerations
Cost: eHF is significantly more expensive than standard formula — emphasise that it is prescribable on NHS prescription. Smell and taste: eHF has a characteristic smell from the hydrolysis process; reassure parents this is normal. Stool change: stools may become looser initially; this normalises over 1–2 weeks. Expected timeline: most infants improve within 1–2 weeks of complete switch; full improvement in 2–4 weeks; if no improvement after 4 weeks of correct eHF use: consider AAF; review diagnosis; exclude other food allergies; paediatric review.
🔬 Monitor
Weight at 2-week review (centile); symptom diary (stool colour; consistency; vomiting; crying; eczema). If no improvement at 4 weeks: confirm full adherence (no standard formula at all); consider switch to AAF; dietitian and allergy team input. SCORAD or eczema assessment at each review. Feeding diary reviewed at each appointment.
💬 For Mrs. Sharma

"The formula I am prescribing today is called an extensively hydrolysed formula. It is different from standard formula because the protein has been broken down into tiny pieces that Priya’s immune system won’t recognise. It is a medical formula — and it goes on prescription, so there is no cost to you. It smells a bit different from what you have been using — that is completely normal. Some babies take a couple of days to get used to the taste. Replace all of Priya’s feeds with this from today."

eHF: first-line formula for non-IgE-mediated CMPA (the iMAP guideline; MAP guidelines). Prescribable on FP10. NOT HA formula (most common SCA error) — HA is partially hydrolysed and NOT appropriate for CMPA. NOT goat’s milk (major cross-reactivity). NOT soy under 6 months. Full switch from day 1; 150–200 ml/kg/day; review at 2–4 weeks. Improvement expected in 1–2 weeks. If no improvement after 4 weeks: AAF; allergy team.

Amino Acid Formula (AAF)
Neocate Infant · Alfamino · Nutramigen AA · PurAmino · for IgE-mediated CMPA; eHF failures; multiple food allergies
✓ Second-line formula for IgE-mediated CMPA or eHF failure — consider after allergy team review
IgE-mediated CMPA (pending allergy testing); eHF failure after 4 weeks; multiple food allergy150–200 ml/kg/day; complete protein source; use as sole formula for indicated period
✓ When AAF is needed
Amino acid formula contains no intact or hydrolysed protein — only free amino acids. The immune system cannot react to individual amino acids. Indications: (1) IgE-mediated CMPA pending allergy testing (10% of infants on eHF still react — AAF eliminates all protein antigen); (2) Non-IgE-mediated CMPA failing to improve after 4 weeks of correct eHF use — switch to AAF; (3) Multiple food allergies (soy + cow’s milk + wheat etc.); (4) Eosinophilic oesophagitis; (5) Short bowel syndrome or malabsorption. All AAFs are prescribable on FP10. In the SCA: the most likely reason to use AAF over eHF is a presentation consistent with IgE-mediated CMPA (immediate reactions; urticaria) — do not delay AAF initiation while waiting for allergy testing in these cases.
✗ NOT first-line for simple non-IgE-mediated CMPA
AAF is not first-line for straightforward non-IgE-mediated CMPA because: (a) it is significantly more expensive than eHF; (b) eHF is sufficient for 90–95% of non-IgE-mediated cases; (c) the taste is more challenging for infants to accept. Reserve AAF for IgE-mediated cases, eHF failures, and complex cases with multiple food allergies or malabsorption. If starting AAF for IgE-mediated CMPA pending allergy testing: allergy team should confirm continued use based on testing results — some infants may be able to step down to eHF once allergy testing confirms no immediate IgE reactions to eHF protein fractions.
⚠ Practical considerations
Taste acceptance: AAF has a distinctive taste (amino acid based); some infants refuse it; gradual introduction (mixing with small amount of eHF or breast milk where tolerated and safe) may help. Completely prescribable on FP10. Available as powder (most AAFs) or ready-to-feed for convenience. If infant is on AAF for prolonged period: dietitian input essential for nutritional adequacy during weaning. Bone density: monitor calcium intake as part of weaning planning.
🔬 Monitor
Weight and growth (weekly initially). Symptom diary: has the allergy picture improved on AAF (compared to eHF)? Allergy team: review timing of formal allergy testing (SPT; specific IgE) on AAF — tests can be performed on AAF without risk of triggering a reaction. Weaning plan: commence via milk ladder under allergy team guidance; in IgE-mediated CMPA this must be supervised (anaphylaxis risk on rechallenge).
💬 For parents

"This formula contains only the most basic building blocks of protein — called amino acids — rather than any protein that your baby’s immune system could react to. It is a complete food source and provides everything your baby needs. It does have a different taste, and some babies take a few days to get used to it. Like all of the special formulas, this is on prescription."

AAF: for IgE-mediated CMPA (pending allergy testing); eHF failure after 4 weeks; multiple food allergy. NOT first-line for straightforward non-IgE-mediated CMPA. Products: Neocate Infant; Alfamino; Nutramigen AA. All prescribable on FP10. Allergy team should confirm continued use and weaning plan. Milk ladder for IgE-mediated CMPA must be supervised by allergy team (anaphylaxis risk).

Infant Gaviscon (Sodium Alginate)
Alginate-based reflux treatment · 1 sachet per feed for formula · half sachet for breastfed · NOT with thickened feeds
✓ For ongoing reflux symptoms alongside eHF; first-line for simple GOR; do NOT use simultaneously with thickened feeds
Simple GOR with symptoms; ongoing reflux symptoms alongside eHF; not for CMPA alone (will not resolve CMPA)Formula-fed: 1 sachet per feed (made up in formula); breastfed: 1 sachet made up in cooled boiled water; max 6 sachets/day
✓ Role in CMPA and GOR management
Infant Gaviscon (sodium alginate + magnesium alginate) forms a viscous gel in the stomach when it reacts with gastric acid, creating a raft that reduces reflux of stomach contents into the oesophagus. It is a physical rather than pharmacological treatment. Role in Priya’s management: can be continued alongside eHF for ongoing reflux symptoms while the CMPA is resolving. It will not treat the CMPA itself but may reduce reflux-related discomfort during the 2–4 weeks of eHF transition while gut inflammation heals. For simple GOR (happy spitter; good growth; no atopy): Infant Gaviscon can be the primary treatment after positioning advice. Important cautions: NOT to be used simultaneously with thickened formula feeds (over-thickening; risk of constipation and bezoar formation) — if using eHF which is standard (not thickened): Gaviscon can be used alongside. NOT suitable for preterm infants (sodium load). Formula-fed dose: 1 sachet per feed. Breastfed dose: half sachet in 15 ml cooled boiled water offered by syringe before feed.
✗ Key cautions
Do NOT use simultaneously with already-thickened formula (e.g. SMA Staydown; Carobel added to formula): over-thickening leads to constipation; risk of intestinal bezoar formation. Not suitable for preterm infants (sodium content). Do NOT prescribe Gaviscon as the sole treatment for CMPA — as Priya’s case demonstrates: two courses of Gaviscon have not helped because the underlying problem is CMPA, not mechanical reflux. In the SCA: prescribing a third course of Gaviscon without formula change for this clinical picture is a Tasks fail.
⚠ Side effects
Constipation (most common; dose-related; reduce to half sachet per feed if constipated). Over-thickening if combined with thickened feeds. Generally well tolerated. Sodium content: relevant in preterm infants (avoid) and in infants with renal impairment. Some infants dislike the thicker feed; persevere for 1–2 days.
🔬 Monitor
Stool frequency and consistency (constipation). Symptom response (reduction in vomiting; comfort after feeds). Weight gain. Consider stopping Gaviscon at the 2-week review if eHF has resolved the reflux symptoms — Gaviscon may no longer be needed once CMPA is treated. Do not continue indefinitely without review of whether it is still contributing to symptom management.
💬 For Mrs. Sharma

"I would like to continue the Gaviscon alongside the new formula for now — it helps with the reflux while the new formula is getting to work on the underlying allergy. Once Priya is better on the new formula, we can decide at the next appointment whether she still needs the Gaviscon. Just remember: do not use the Gaviscon with a thickened formula — that can cause constipation."

Infant Gaviscon: alginate-based; for GOR and ongoing reflux alongside eHF. NOT a treatment for CMPA itself. Third course of Gaviscon without formula change = Tasks fail in SCA. Formula-fed: 1 sachet per feed. Breastfed: half sachet in 15 ml cooled water by syringe. NOT with thickened feeds. NOT in preterm. Constipation: reduce dose. Discontinue at review if eHF has resolved symptoms.

Omeprazole (Paediatric) — GORD with Complications Only
NOT for simple GOR · NOT as diagnostic trial · NOT for CMPA · 0.7–1.4 mg/kg/day · GORD with confirmed complications
✓ ONLY for confirmed GORD with complications — NOT for simple GOR or CMPA
GORD with: faltering growth; oesophagitis; aspiration — NOT for crying; NOT for simple refluxOmeprazole: 0.7–1.4 mg/kg/day; maximum 20mg; licensed from 1 year (unlicensed under 1 year — prescribing decision with senior support)
✓ When PPI is appropriate in infants
Proton pump inhibitors (omeprazole; lansoprazole) suppress gastric acid production and reduce oesophageal damage from acid reflux. Appropriate use in infants: (1) confirmed GORD with oesophagitis (haematemesis; severe pain at feeds; significant faltering growth directly attributable to GORD); (2) aspiration syndrome from GORD (recurrent lower respiratory tract infections; wheeze); (3) after Infant Gaviscon trial has failed to control symptoms and a secondary GORD diagnosis is confirmed (not just suspected). NICE NG1: PPI should be considered ONLY after lifestyle measures and alginate (Gaviscon) have been tried and found insufficient, AND there is clear evidence of GORD with complications. Omeprazole is unlicensed under 1 year (licensed from 1 year in the UK) but is widely used off-label in infants — document the prescribing rationale.
✗ PPI is NOT appropriate for
Simple infant GOR (physiological reflux — happy spitter): multiple RCTs show no benefit over placebo in non-GORD infants. Omeprazole does not reduce crying, improve sleep, or reduce vomiting in infants without true oesophageal inflammation. If prescribed for simple GOR: exposes infant to side effects without benefit. CMPA: omeprazole treats acid reflux — not the immune-mediated gut inflammation of CMPA. Prescribing omeprazole for CMPA without formula change treats the wrong mechanism. Diagnostic trial of PPI: not recommended (no RCT evidence that a short trial differentiates GORD from GOR in infants).
⚠ Side effects
Hypomagnesaemia (with long-term use). Increased risk of respiratory and GI infections (acid suppression impairs normal defence mechanisms). C. difficile risk (with prolonged use in older patients; less evidence in infants). Interstitial nephritis (rare; long-term). GI effects: diarrhoea; constipation; abdominal pain. Head circumference monitoring if prolonged use (some studies suggest magnesium association with development). Do not use beyond 4–8 weeks without specialist review.
🔬 Monitor
Weight gain at every review (PPI is being used to enable weight gain in GORD). Symptom response: reduction in pain at feeds; improvement in feeding; weight recovery. Review at 4–8 weeks: if not improving on PPI: consider re-evaluation of diagnosis; specialist review. Stop when no longer needed — PPI should not continue indefinitely without review. Renal function: if prolonged use.
💬 For parents

"This tablet helps reduce the acid in your baby’s stomach, which should make the reflux less painful. I want to be clear: we are using it because we have evidence that the acid is causing a real problem — not just as a trial. I want to review Priya in 4 weeks to make sure it is making a difference."

Omeprazole in infants: ONLY for confirmed GORD with complications (faltering growth; oesophagitis; aspiration). NOT for simple GOR. NOT as diagnostic trial. NOT for CMPA (wrong mechanism). Unlicensed under 1 year — document rationale. Dose: 0.7–1.4 mg/kg/day; max 20mg. Review at 4–8 weeks. Evidence: multiple RCTs show NO benefit over placebo for crying infants without GORD. Prescribing omeprazole for Priya without first changing formula = Tasks fail in SCA.

Adrenaline Auto-Injector (EpiPen Junior 150 mcg)
ONLY for IgE-mediated CMPA with anaphylaxis risk · NOT for non-IgE-mediated · EpiPen Junior 150 mcg for infants/children under 15 kg
✓ Prescribed for IgE-mediated CMPA with anaphylaxis history or risk — NOT for Priya (non-IgE-mediated)
IgE-mediated CMPA with anaphylaxis features only — confirmed or high suspicionEpiPen Junior 150 mcg IM thigh; carry at all times; 2 devices prescribed; written allergy action plan
✓ IgE-mediated CMPA — Anaphylaxis Management
EpiPen is indicated for IgE-mediated CMPA where there is: (a) a history of anaphylaxis to cow’s milk (systemic IgE reaction involving respiratory or cardiovascular compromise); (b) suspected anaphylaxis risk (immediate urticaria; angioedema; wheeze on milk exposure without cardiovascular compromise — decision to prescribe based on allergy team assessment). EpiPen Junior (150 mcg adrenaline) IM thigh: for infants and children under 15 kg. Administer to anterolateral thigh (lateral middle third). Prescription: 2 devices (one primary; one backup); written allergy action plan (provided by allergy team); 999 called after administration (adrenaline wears off in 10–20 minutes; biphasic anaphylaxis risk). Training: parents and nursery/school staff must be trained. Allergy team provides this training. Do not prescribe EpiPen without allergy team involvement and training.
✗ NOT for non-IgE-mediated CMPA
EpiPen is NOT indicated for non-IgE-mediated CMPA (Priya’s case). Non-IgE-mediated reactions do not cause anaphylaxis — they cause delayed gut and skin inflammation. Prescribing an EpiPen for non-IgE-mediated CMPA — or for formula intolerance — is not appropriate and creates unnecessary parental anxiety. EpiPen is a high-risk medication: incorrect use or storage can cause serious cardiac events. Ensure the indication is confirmed by allergy team before prescribing.
⚠ Administration and education
Storage: room temperature; do not refrigerate (adrenaline precipitates in cold); away from direct sunlight; check expiry date regularly. Administration: remove from case; hold dominant fist; orange tip down; press firmly into outer mid-thigh (through clothing); hold for 10 seconds; remove; massage for 10 seconds; call 999. Biphasic anaphylaxis: symptoms may return 1–8 hours after first EpiPen; hospital observation for 4 hours after adrenaline administration. Written allergy action plan: provided by allergy team; must accompany child at all times; shared with nursery/school. Two devices: use first if needed; second if first fails or symptoms return before ambulance arrives.
🔬 Monitor
Annual review of EpiPen prescription (weight; device size; parental training refresher). Allergy team follow-up: repeat allergy testing to assess natural resolution; as child grows, reassess whether EpiPen is still required. Device expiry: check annually; renew before expiry date. Check whether child’s weight has now exceeded 15 kg threshold (switch to EpiPen standard 300 mcg at ≥15–25 kg; Epipen 500mcg at >25 kg).
💬 For parents

"Because of the reaction Priya had — with the hives and the swelling — I want to make sure you have this pen at all times. If you see those signs again — hives; swelling; difficulty breathing — you use the pen in the outer thigh and call 999 immediately. The nurse from the allergy clinic will train you on how to use it and give you a written plan. You should always carry two."

EpiPen: ONLY for IgE-mediated CMPA with anaphylaxis history or risk (confirmed by allergy team). NOT for non-IgE-mediated CMPA (Priya). EpiPen Junior 150 mcg for <15 kg. 2 devices prescribed. Written allergy action plan essential. Train parents and nursery staff. 999 after administration. Annual review. Do not prescribe EpiPen for CMPA without allergy team involvement.

Emollient + Topical Hydrocortisone 1% (Eczema Management)
Diprobase cream / Epaderm / Hydromol · Topical HC 1% for active flares · face-safe; do not thin skin with prolonged use
✓ Emollient twice daily + HC 1% for active eczema — prescribe alongside eHF from first appointment
All CMPA with eczema: prescribe emollient + topical HC 1% at first appointmentEmollient: generous amount twice daily + after bath; HC 1%: apply to active areas twice daily for 5–7 days; then stop until next flare
✓ Eczema management alongside CMPA
Priya has atopic dermatitis (eczema) on her cheeks: a marker of CMPA and a condition requiring its own treatment. Emollient therapy: Diprobase cream (cheap; widely available; NHS prescribable); Epaderm; Hydromol; E45 (avoid E45 under 2 years — it contains lanolin which can sensitise). Apply generously (“dripping with cream”) to all skin twice daily and after bathing — not just to affected areas. Emollient repairs the skin barrier disrupted by atopic inflammation and reduces the frequency of flares. Topical hydrocortisone 1%: weakest topical corticosteroid; face-safe for infants; apply to red/inflamed eczema areas twice daily for 5–7 days; then stop; use again at next flare. CMPA treatment (eHF) will improve eczema over 2–4 weeks as the underlying cow’s milk allergy resolves — but emollient and topical HC should be used concurrently to treat the active inflammation.
✗ Step-up if not responding
HC 1% inadequate for moderate-severe eczema: step up to hydrocortisone 2.5% (face) or betamethasone valerate 0.025% (body; avoid face). Calcineurin inhibitors (tacrolimus; pimecrolimus): second-line; licensed from 2 years. Severe/widespread eczema: paediatric dermatology referral. Do not use potent topical corticosteroids (betamethasone 0.05%; clobetasol) on infants’ faces without specialist advice — skin thinning and systemic absorption risk is high on infant skin.
⚠ Practical points for eczema in infants
Emollient technique: use spoon or spatula to scoop out (fingers contaminate the pot with bacteria). Pat skin dry after bath rather than rubbing. Fingertip unit for topical corticosteroids: 1 FTU covers an area of skin the size of two adult palms. Bath additives (e.g. Oilatum): some evidence for benefit; acceptable to use. Avoid soap; use soap substitute (Diprobase cream as soap substitute in bath; or Cetraben). Review SCORAD or IGA at 2–4 weeks to document improvement. If eczema worsens despite eHF: consider additional food allergies (soy; egg; wheat — common co-allergens in eczema); paediatric dermatology referral.
🔬 Monitor
SCORAD or IGA score at each review (baseline; 2 weeks; 4 weeks). Improvement in eczema on eHF confirms CMPA as the trigger. Persistent eczema despite eHF: consider AAF; additional food allergy investigation; dermatology referral. Infection (Staphylococcal): check for golden crusting; swab if infected; topical fusidic acid + HC (Fucidin H) for mild; systemic antibiotics (flucloxacillin) for widespread. Skin thinning if topical steroid used chronically on same area: minimum quantity for shortest time; rest periods.
💬 For Mrs. Sharma

"I am also going to prescribe a moisturising cream for Priya’s skin — you should use it generously twice a day, every day, not just when she has a rash. Think of it as feeding her skin. And I am going to prescribe a mild steroid cream for the red patches — use it on the rash twice a day for a week when it flares up; then stop when it clears. The formula change should also start to help her skin — most babies see real improvement in the eczema within 2–4 weeks."

Emollient + HC 1%: prescribe at first appointment alongside eHF for all CMPA with eczema. Emollient twice daily (Diprobase; Epaderm); HC 1% twice daily to active areas for 5–7 days. Face-safe. Eczema will improve as CMPA resolves on eHF over 2–4 weeks — but treat the acute inflammation now. SCORAD at baseline and review. Step up to HC 2.5% or betamethasone 0.025% if inadequate response. Paediatric dermatology if severe. Topical calcineurin inhibitors (tacrolimus): from 2 years only.

7G — Psychosocial impact of CMPA on the family
🧑️
The impact of an infant with CMPA extends far beyond the formula prescription
Managing an infant with CMPA requires parents to make significant dietary and feeding changes at one of the most stressful periods of their lives. The burden falls disproportionately on the primary caregiver (usually the mother) and includes: persistent anxiety about accidental milk exposure; social isolation (difficulty feeding out); guilt and self-blame; financial cost; and the emotional weight of seeing an infant in discomfort for months before diagnosis. The GP’s role is not just to prescribe eHF — it is to support the family through the diagnosis and its implications.
💕
Maternal Guilt

Mrs. Sharma is carrying guilt about stopping breastfeeding. CMPA occurs in breastfed infants too — the management would simply have been maternal dairy-free diet. Stopping breastfeeding did not cause CMPA and would not have prevented it. The GP must address this directly without minimising: “stopping breastfeeding when you were in pain was the right decision.”

"Can I say something about the breastfeeding? Stopping when you did was the right thing to do — you were in pain, and continuing was not sustainable. Cow’s milk allergy happens in breastfed babies too. This is not something you caused."
😴
Parental Exhaustion

Four months of broken sleep is a medical concern. Parental exhaustion increases the risk of PND; reduces ability to implement feeding changes accurately; increases risk of errors in formula preparation; and reduces capacity to respond appropriately to infant cues. EPDS is essential. Practical support (partner involvement; family help; health visitor home visits) is clinically as important as the prescription.

"I also want to check in about you. How are you coping with the sleep? Is there anyone helping you? I want to make sure you have some support too — not just for Priya’s sake but for yours."
🏫
Weaning and Social Feeding

CMPA affects weaning planning: dairy-containing solids cannot be introduced at 6 months without the milk ladder; this requires dietitian input and careful planning. Social feeding (attending baby groups with snacks; birthday parties; nursery) becomes more complex. Parents need information about hidden dairy in food labels and how to communicate the allergy to childcare providers.

"When Priya starts on solid food at around 6 months, the dietitian will help you work out how to introduce things gradually — there is a specific order and timeline that means most babies can have normal dairy food by the time they start school."
🎁
Prognosis and Hope

The single most important message to give Mrs. Sharma alongside the diagnosis is the prognosis: 90% of children with non-IgE-mediated CMPA develop complete tolerance by age 5. Most children are tolerating baked milk products by 12–18 months. This is not a lifelong condition. The GP who gives this clear, specific, hopeful message provides something Mrs. Sharma can hold onto during the difficult weeks of the eHF transition.

"The really good news — and this is important — is that 9 out of 10 children with this type of allergy grow out of it completely by the time they are 5. Most children are eating normal dairy food — cheese; yoghurt; everything — by school age. This is not going to last forever."
7H — Follow-up
T
Today — eHF prescribed; EPDS; eczema management; referrals

eHF (Nutramigen 1 with LGG or Aptamil Pepti 1) prescribed on FP10; explained to Mrs. Sharma; complete switch from today. Infant Gaviscon continued alongside. Emollient (Diprobase) + topical HC 1% prescribed for eczema. EPDS administered; result documented. Health visitor alerted. Dietitian referral made. Allergy team referral. 2-week review booked before leaving.

2-week review booked before Mrs. Sharma leaves
2
2 Weeks — Weight recheck; symptom diary review; eHF response

Weight (plot on centile); feeding diary review (stool normalisation; reduction in crying/vomiting; eczema improvement); eHF adherence confirmed (complete switch; no standard formula). If improving: confirm CMPA diagnosis; continue eHF; book 4-week review. If not improving: review adherence; consider formula preparation; check for any dairy in diet; consider AAF if fully adherent and no improvement. EPDS recheck if previous score was elevated.

Weight; symptom diary; adherence check; EPDS if elevated at first appointment
3
4–6 Months — Allergy team review; milk ladder planning

Allergy team review (if referred). Weaning planning: dietitian advises on milk ladder starting from 6 months. Milk ladder step 1: baked milk products (biscuits, cakes). Weight; centile; developmental check. SCORAD eczema review. If well-controlled on eHF: trial of milk ladder (baked milk) supervised by dietitian/allergy team. If any IgE features emerge: SPT or specific IgE before milk ladder.

Allergy team; milk ladder planning; weaning advice; dietitian
4
12 Months — Milk ladder progression review

Review milk ladder progress (most non-IgE-mediated CMPA tolerates baked milk by 12–18 months). If milk ladder progressing well: continue through steps under dietitian guidance. Annual allergy review. Eczema management review: does eczema improve as CMPA resolves? Any other allergies emerging at weaning (egg; peanut — now recommend early introduction at 4–6 months as allergy prevention in atopic infants: LEAP trial).

Milk ladder; annual allergy review; new allergen introduction timing; eczema
5
Age 3–5 — CMPA resolution expected

90% of non-IgE-mediated CMPA resolves by age 5. Full review at 3 and 5 years with allergy team: has Priya developed complete tolerance? Formal rechallenge if not spontaneously tolerating. If tolerance confirmed: discharge from CMPA monitoring; normal dairy diet. If persisting: review whether IgE-mediated component (repeat SPT/specific IgE); ongoing specialist follow-up; school alert and management plan.

Resolution expected by 5 years; formal rechallenge if not spontaneously tolerating
7I — Monitoring

CMPA monitoring mnemonic: WASTE

Weight: centile plot at every review. Allergy features: new IgE-mediated features; new food allergies at weaning. Stools: normalisation from green/watery to normal formula stool (yellow; seedy) within 2–4 weeks confirms eHF response. Twenty-four hours: symptom diary; feeding diary reviewed at each appointment. Eczema: SCORAD at each review; improvement confirms CMPA diagnosis.

ParameterTimingAction threshold
Weight (centile)Every review (minimum at 2 weeks; 4 weeks; 3 months)No weight gain on eHF: review adherence; dietitian; consider AAF. ≥2 centile drop: urgent paediatric referral
Stool characterSymptom diary; review at 2 weeksNormalisation within 2–4 weeks confirms eHF response. Persistent green stools: review adherence; consider AAF
Eczema (SCORAD)Baseline; 2 weeks; 4 weeksImprovement confirms CMPA. Worsening: additional food allergen; dermatology referral
Vomiting frequencySymptom diary; 2 weeksReduction in 1–2 weeks. Persistent: check Gaviscon adherence; consider GORD complications; paediatric review
Maternal EPDSAt first appointment; if elevated: 2 weeksEPDS ≥13: PND management; HV support; NHS Talking Therapies; sertraline. Q10 ≥1: urgent mental health referral
MilestoneAction
2–4 weeks on eHFReview response; if improving: confirm CMPA; continue eHF; dietitian. If not improving: review adherence; switch to AAF
6 months — weaningMilk ladder planning with dietitian; start baked milk if well-controlled non-IgE-mediated
12 monthsMilk ladder progression; annual allergy review; peanut/egg introduction timing (LEAP)
3 yearsAllergy review: resolution assessment; SPT/specific IgE if IgE-mediated concern
5 yearsFinal resolution review; formal rechallenge if not tolerating; school management plan if ongoing
7J — Safety-netting

⚠ Three critical safety-nets for Mrs. Sharma

🔴 Emergency — anaphylaxis features
"If Priya ever develops sudden hives or a rash all over her body; any swelling of her face or lips; any difficulty breathing; goes very pale or floppy — call 999 immediately. Do not wait. This has not happened before, but I want you to know the signs just in case."
IgE-mediated reactions can emerge as CMPA evolves or as new allergens are introduced at weaning. Pre-warning parents of anaphylaxis signs — even in a non-IgE-mediated case — is appropriate preparation for any food allergy family. If anaphylaxis signs ever appear: urgent allergy referral and EpiPen prescription.
💊 Formula — complete switch from today; no mixing
"I want to be clear: Priya needs to be completely on this new formula from today. If any of the old formula is given — even just one bottle — it will stop us knowing whether the change is working. No mixing. If you run out before the next prescription, you can call the surgery for an urgent prescription."
Incomplete formula switch is the most common reason eHF trials appear to fail — parents give old formula for night feeds or when eHF runs out. Being explicit about this prevents the most common management failure.
🟠 Review — when to come back sooner
"I want to see Priya in 2 weeks — that appointment is booked. But I want you to ring us sooner if: she is losing weight; she is not keeping feeds down; she develops any new breathing problems; or you are struggling with the formula change. Please do not wait 2 weeks if any of those things happen."
The 2-week review is essential — but the GP must give a clear list of reasons to come back earlier. Faltering growth continuing despite eHF switch is a paediatric referral trigger.
2 weeksWeight; symptom diary; eHF adherence; EPDS recheck if elevated
4–6 monthsAllergy team; milk ladder; weaning planning; eczema SCORAD
3–5 yearsResolution review; rechallenge; school management plan if persisting
🎓 SCA Checkpoint — Step 7 (Final)TasksRelating to OthersGlobal Skills
Closing the consultation
"Let me pull together what we have decided. The Gaviscon has not been enough because the underlying problem is cow’s milk protein allergy — not just mechanical reflux. I am prescribing a new formula today — it goes on prescription so there is no cost to you. Priya needs to be fully on this from today. No mixing."
"I have also prescribed a moisturising cream and a very mild steroid cream for the rash on her cheeks. Use the moisturiser every day; the steroid cream only when the rash is active."
"I have referred Priya to a dietitian and to the allergy team. The dietitian will help plan how to gradually reintroduce milk products as Priya gets older — most children can eat normal dairy food by school age."
"Before you go — I want to check how you are feeling about all of this. Is there anything I haven’t answered? And I am going to book you in for 2 weeks — I want to see how Priya is getting on and check her weight."
Deductions
  • Prescribing HA/partially hydrolysed formula (SMA HA; Aptamil Comfort) — NOT appropriate for CMPA; most common SCA prescribing error
  • Prescribing goat’s milk formula — 90% cross-reactivity with cow’s milk; absolutely wrong
  • Ordering specific IgE or skin prick test for non-IgE-mediated presentation — will be negative; causes false reassurance
  • Prescribing a third course of Gaviscon without formula change — treating the wrong diagnosis
  • Not plotting weight on centile chart — severity marker not assessed
  • Prescribing omeprazole without confirmed GORD with complications
Tasks — full criteria
  • CMPA diagnosed (non-IgE-mediated): eczema + atopy + green stools + growth faltering + Gaviscon failure
  • eHF prescribed (NOT HA; NOT goat’s milk)
  • No allergy test ordered (explained why)
  • Weight plotted; centile drop documented and acted on
  • IgE features specifically excluded
  • EPDS administered; dietitian and allergy team referred
  • Eczema: emollient + HC 1%
  • 2-week review booked
Relating to Others
  • Maternal acknowledgement; 4 months of a crying baby
  • Breastfeeding guilt addressed directly
  • Gaviscon validated as appropriate first step
  • Prognosis given: 90% resolve by age 5
  • Plain-language explanation of CMPA
  • 2-week review booked before Mrs. Sharma leaves
🔴 Red
HA formula prescribed; goat’s milk formula; third course Gaviscon; omeprazole without indication; allergy test ordered for non-IgE presentation; weight not plotted; no referral; no maternal wellbeing assessment
🟠 Amber
eHF correctly prescribed; CMPA diagnosed; weight plotted; allergy test not ordered; EPDS done; no eczema management; dietitian not referred; breastfeeding guilt not addressed; no 2-week review booked
🟩 Green
Maternal acknowledgement; breastfeeding guilt addressed; eHF (not HA; not goat’s) prescribed with explanation; no allergy test + reason explained; weight plotted + centile documented; IgE features excluded; EPDS done; emollient + HC 1%; dietitian + allergy team referred; HV alerted; 2-week review booked before leaving; prognosis (90% resolve by 5) communicated
CMPA & Reflux in Children — SCA Consultation Scorecard
NICE NG1 · iMAP · MAP Guidelines · Non-IgE-mediated CMPA · eHF (NOT HA formula) · No allergy test · Weight on centile · EPDS
0/ 33 pts
🌐
Global Skills
Structure, language, person-centred approach
0/7
Tasks
Clinical reasoning, prescribing, co-ordination
0/15
🤝
Relating to Others
Empathy, communication, patient-centred care
0/11
RAG Self-Assessment
🔴 Red
No maternal acknowledgement; HA formula prescribed; goat’s milk prescribed; third course Gaviscon without formula change; allergy test ordered for non-IgE presentation; weight not plotted; omeprazole prescribed without GORD indication; no EPDS; no dietitian referral; breastfeeding guilt not addressed
🟠 Amber
Empathetic opener; CMPA correctly diagnosed; eHF prescribed; weight plotted; allergy test not ordered; no eczema management; EPDS not administered; dietitian not referred; breastfeeding guilt not addressed; no 2-week review booked; prognosis not given
🟩 Green
Maternal acknowledgement; open question; ICE all 3; breastfeeding guilt addressed; Gaviscon validated; eHF (not HA/goat’s) prescribed on FP10; no allergy test + plain language explanation; weight + centile; IgE features excluded; EPDS; emollient + HC 1%; dietitian + allergy team; 2-week review booked; vitamin D; prognosis 90% by 5; closing question
011172533
Fail
Borderline
Pass
Strong pass
📋
Complete the checklist to see your score and feedback
"I’m really worried about her. She’s been like this since she was three weeks old — crying, arching her back, not settling. The health visitor said it was reflux and gave us Gaviscon but it’s done nothing. I’ve been up half the night for four months. I just want someone to actually help us."
Who you are

Anita Sharma, 28, first-time mother. Baby Priya is 4 months old. Priya was born at term and breastfed for 2 weeks, but Anita developed mastitis and latching difficulties so switched to SMA First. Anita feels guilty about stopping breastfeeding and is worried it has caused Priya’s problems. She has been sleeping about 4–5 hours of broken sleep per night since Priya was born. Her husband works long hours. She has been researching online and wonders if Priya has cow’s milk protein allergy — she wants someone to confirm or deny this.

Hidden agenda — disclose if GP creates space

Breastfeeding guilt (disclose if GP addresses it, or if GP says CMPA is not her fault): “I stopped breastfeeding at 2 weeks because I had mastitis and it was agony. But then when Priya started getting worse, I kept thinking — did I do this? Did switching to formula cause this?” Respond well if GP says: "Stopping when you were in pain was the right decision — breastfed babies get this allergy too." Then visibly relieved: “Really? I’ve been blaming myself for months.”

CMPA self-diagnosis (share if GP asks about ideas): “I looked it up online — a lot of what they describe sounds exactly like Priya. Cow’s milk protein allergy. Is that what this is?” Respond well if GP validates: “Oh, good — I was worried you’d think I’d been on Dr Google too much.”

Health visitor relationship (raise if GP asks about ICE or previous management): “I don’t want to get the health visitor in trouble — she was really helpful. I just feel like the Gaviscon hasn’t done anything and I needed to see someone else.” Respond well if GP validates the health visitor’s initial management: “OK. That makes sense.”

Responses to key conversations
  • On CMPA diagnosis: "So it is an allergy? Not just reflux?" — respond to clear explanation: "OK. So the Gaviscon was never going to fix it because it was the wrong problem? That actually makes sense."
  • On eHF formula: initially: "Will it actually work? We have already tried changing things and nothing has helped." — respond to explanation of mechanism and evidence: "OK. And it’s on prescription? I didn’t know you could get formula on prescription."
  • On no blood test: initially puzzled: "Don’t you need to test to know for sure?" — respond to explanation: "Oh — so the formula change is the test. That’s interesting. OK."
  • On prognosis: visibly relieved: "90% grow out of it? I thought this might be forever." — this is the emotional turning point of the consultation; the actor should show visible emotional shift here.
  • On eczema cream: "I hadn’t thought of the rash as being part of the same problem. That makes sense actually."
Clinical details
  • Baby Priya: 4 months; term birth; 3.8 kg at birth (50th centile); now 4.2 kg (25th centile)
  • Formula: SMA First since 2 weeks; Infant Gaviscon ×2 (no benefit)
  • Symptoms since 3 weeks: crying after feeds; back-arching; vomiting 1–2 times per feed; green watery stools
  • Eczema: both cheeks (mild to moderate)
  • Family atopy: father asthma; mother hayfever
  • No bilious vomiting; no blood in stool; no apnoea; no fever
  • Mrs. Sharma: EPDS (administer in consultation) — likely score 9–11 (sleep deprivation; infant illness; guilt; anxiety); borderline PND; close follow-up needed
"The health visitor said it was just reflux and Gaviscon would help. Why isn’t she right? Should I have come sooner? Have I been doing something wrong all along? Have I made things worse by waiting?"

Resolution: Mrs. Sharma accepts the CMPA diagnosis and eHF prescription if: the health visitor is not criticised; the breastfeeding guilt is addressed directly; the formula change is explained clearly in plain language; and a 2-week review is booked before she leaves. She is visibly relieved when the prognosis is given (90% resolve by 5). She leaves saying: “I feel like I finally have an actual answer. I’ve been going round in circles for months.”

🏥
Clinic Quick Reference
CMPA & Reflux in Children Framework
NICE NG1 · iMAP · MAP Guidelines · eHF first-line · NOT HA formula · NOT goat’s milk · No allergy test for non-IgE · EPDS · Milk ladder
expand
💊 1 — IgE vs Non-IgE CMPA: The Critical Distinction
Infant with possible CMPA → Is this IgE-mediated or non-IgE-mediated?
IgE-mediated: immediate reaction <2 hours; urticaria; angioedema; wheeze; anaphylaxis. Allergy testing indicated (SPT; specific IgE). Formula: AAF (not eHF until tested). EpiPen if anaphylaxis risk. URGENT allergy referral (2 weeks).
Non-IgE-mediated (most common; Priya’s type): delayed reaction 2–72 hours; green/watery stools; colic; eczema; faltering growth. No allergy test (will be negative). Formula: eHF (Nutramigen; Aptamil Pepti). Diagnosis = elimination trial + response.
Formula prescription: eHF on FP10; complete replacement of standard formula from day 1; 150–200 ml/kg/day; review in 2–4 weeks. NOT HA formula; NOT goat’s milk; NOT soy under 6 months.
Breastfed infant with CMPA: maternal dairy-free diet 2–4 weeks (NOT formula change — continue breastfeeding). Maternal calcium 1000mg + vitamin D 10 mcg daily.
2–4 week review: weight; stool normalisation; eczema; symptom diary · If improving: CMPA confirmed · If not: AAF; allergy team · Dietitian: milk ladder from 6 months · 90% resolve by age 5
📋 2 — Key Clinical Numbers
IgE: <2h
IgE-mediated reaction timing (urticaria; angioedema; wheeze); allergy test indicated; AAF; EpiPen
non-IgE: 2–72h
Non-IgE-mediated reaction timing (delayed); no allergy test; eHF; clinical elimination trial
eHF = first-line
NOT HA formula; NOT goat’s milk; NOT soy under 6 months; prescribe on FP10
2–4 weeks
Elimination trial duration; most infants improve within 1–2 weeks; full response by 4 weeks
90% by age 5
Non-IgE-mediated CMPA resolution; 60% by age 2; 80% by age 3; 90% by age 5
2–3%
CMPA incidence in infants; most common food allergy in the first year of life
EPDS ≥13
Probable PND in mother; sertraline; CBT; NHS Talking Therapies; HV intensive support. Q10 ≥1: urgent psychiatric referral
2 centile drop
Urgent paediatric referral threshold; 1 centile drop (Priya): eHF + 2-week review + dietitian
150–200 ml/kg/day
eHF formula volume for infants (same as standard formula); complete switch from standard formula
6 months
Milk ladder starting age for non-IgE-mediated CMPA; step 1: baked milk; supervised by dietitian/allergy team
70% at 4 months
Physiological GOR prevalence at peak age; resolves spontaneously by 12–18 months without treatment
Omeprazole: GORD only
PPI NOT for simple GOR; NOT as diagnostic trial; NOT for CMPA; 0.7–1.4 mg/kg/day if indicated
⚠ 3 — Key Clinical Rules
eHF NOT HA formula — HA (Aptamil Comfort; SMA HA) is partially hydrolysed and NOT appropriate for CMPA diagnosis or treatment No allergy test for non-IgE-mediated CMPA — will be negative; causes false reassurance; diagnosis is clinical Goat’s milk formula NOT appropriate — approximately 90% cross-reactivity with cow’s milk; absolutely contraindicated in CMPA Omeprazole NOT for simple GOR or CMPA — multiple RCTs: no benefit over placebo for non-GORD infants; only for confirmed GORD with complications Breastfed infant with CMPA: maternal dairy-free diet (NOT formula change); continue breastfeeding; maternal calcium 1000mg + VitD 10 mcg eHF failure after 4 weeks: switch to AAF; review adherence; allergy team; exclude multiple food allergies EPDS mandatory in exhausted new mother with chronically unwell infant — PND rate higher in mothers of infants with chronic health problems Prognosis is reassuring for non-IgE-mediated CMPA: 90% resolve by age 5; most tolerate baked milk within 12–18 months
🔬 4 — WASTE Monitoring Mnemonic
WASTEParameterTimingAction
W — WeightCentile chart; plot every reviewToday; 2 weeks; 4 weeks; 3 months1 centile drop (Priya): eHF + 2-week review + dietitian. ≥2: paediatric referral
A — Allergy featuresNew IgE features; new food allergy at weaningEvery review; at weaning (6 months)New urticaria/wheeze/angioedema: IgE-mediated; allergy referral; EpiPen; AAF
S — StoolsCharacter; frequency; colourSymptom diary; 2-week reviewNormalisation within 2–4 weeks confirms eHF response. Persistent: adherence; AAF
T — Twenty-four hoursSymptom diary; feeding diaryKept between today and 2-week reviewReview diary at 2 weeks; objective evidence of eHF response
E — EczemaSCORAD; distribution; severityBaseline; 2 weeks; 4 weeksImprovement confirms CMPA. Worsening: additional food allergen; dermatology
🎓
SCA Exam Quick Reference
CMPA & Reflux — eHF (NOT HA) · No Allergy Test · Weight on Centile · EPDS · Breastfeeding Guilt · 90% by 5
NICE NG1 · iMAP · MAP Guidelines · Non-IgE diagnosis = elimination trial; not allergy test
expand
💬 Opening & ICE
Opener (must do first): “Before we go through everything — four months of a baby who won’t settle is really tough. Tell me in your own words what has been going on.” — open question; space for narrative; breastfeeding guilt will only emerge if this space exists
ICE — Ideas: “What do you think is causing Priya’s symptoms? Have you looked anything up?” — Mrs. Sharma has likely self-diagnosed CMPA; validate this; do not dismiss internet research
ICE — Concerns: “What worries you most? And is there anything you have been blaming yourself for?” — the second question specifically creates space for breastfeeding guilt without making assumptions
ICE — Expectations: “What would today feel like it had been useful if we got there?” — Mrs. Sharma wants: an explanation that makes sense; a concrete different plan; reassurance that nothing serious is missed
Challenge: “The health visitor said Gaviscon would help — why hasn’t she right?” — “The health visitor was completely right to start there — at the time it looked like straightforward reflux. The features that suggest something more — the eczema, the family history, the green stools — have become clearer, and that is pointing us in a different direction now.” Do NOT criticise the health visitor.
Breastfeeding guilt: “Stopping breastfeeding when you were in pain was the right decision. Breastfed babies get this allergy too — the management would have been different, but this is not caused by stopping breastfeeding.” Must be addressed directly; do not imply different outcome if she had continued.
Prognosis: “9 out of 10 children with this type of allergy grow out of it completely by age 5. Most are eating normal dairy food by school age.” — this is the emotional turning point; give it with genuine conviction; visible relief in the actor.
✅ Key SCA Tasks (15pt)
CMPA diagnosed (not GOR) (2pt): eczema + family atopy + green stools + 1 centile drop + Gaviscon failure ×2 + delayed symptom onset 1 week after formula introduction = non-IgE-mediated CMPA; NOT simple physiological GOR
eHF prescribed (NOT HA) (2pt): Nutramigen 1 with LGG; Aptamil Pepti 1; or SMA Althera; on FP10; complete switch from today; 150–200 ml/kg/day. NOT SMA HA; NOT Aptamil Comfort; NOT goat’s milk; NOT soy under 6 months
No allergy test ordered + explained (2pt): SPT and specific IgE are NEGATIVE in non-IgE-mediated CMPA (by definition); ordering them causes false reassurance; diagnosis = elimination trial + response. “The formula change is the most reliable test we have.”
Weight plotted on centile chart (2pt): weigh Priya naked/in nappy; plot on RCPCH 0–4 chart; 50th → 25th = 1 centile drop; document; 2-week weight recheck; dietitian. Not weighing = automatic Tasks deduction
IgE features specifically excluded (2pt): “Has Priya ever had a sudden reaction after a feed — any rash; swelling; difficulty breathing — within 2 hours?” Documented: no urticaria; no angioedema; no wheeze; no anaphylaxis — confirms non-IgE-mediated management appropriate
EPDS administered (1pt): 10-item questionnaire; 2–3 minutes; Mrs. Sharma has multiple PND risk factors. ≥13: PND management. Q10 ≥1: urgent psychiatric referral
Dietitian referral (1pt): milk ladder; weaning; formula volume confirmation; nutritional monitoring on eHF; calcium monitoring. Not optional for a child with faltering growth on a special formula
Eczema: emollient + HC 1% (1pt): Diprobase twice daily; HC 1% to active areas twice daily for 5–7 days; face-safe; SCORAD at baseline
2-week review booked before leaving (1pt): weight; stool diary; eHF adherence; eczema. Book before Mrs. Sharma leaves — open-ended “come back if concerned” does not score
Vitamin D discussed (1pt): 8.5–10 mcg daily; check formula volume; if <500ml/day: supplement; Healthy Start vitamins if eligible
🔴 Prescribing HA formula = automatic 2pt deduction — most common SCA prescribing error in paediatric CMPA
🔴 Ordering allergy test for non-IgE-mediated = Tasks fail — shows misunderstanding of CMPA classification
👥 Relating to Others (11pt)
Maternal acknowledgement (1pt): name the exhaustion specifically; not just "this sounds hard"
Open question first (1pt): Mrs. Sharma’s narrative before clinical checklist; listen for 90 seconds without interrupting
ICE: Ideas (1pt): validate Mrs. Sharma’s CMPA self-diagnosis; do not dismiss internet research; “You are absolutely right — that is exactly what I am thinking”
ICE: Concerns (1pt): second ICE question: “is there anything you have been blaming yourself for?” — explicitly creates space for breastfeeding guilt
ICE: Expectations (1pt): what does Mrs. Sharma want from today; validate and deliver specifically
Breastfeeding guilt (1pt): must be addressed directly; not implied; “this is not caused by stopping breastfeeding; breastfed babies get this too; stopping was the right decision”
Gaviscon validated (1pt): health visitor not criticised; previous management validated; clinical picture has evolved
eHF in plain language (1pt): “protein broken down into fragments the immune system won’t recognise” — mechanism explained without jargon
No allergy test explained (1pt): “blood test would be negative because this type doesn’t involve IgE antibodies — the formula change is the test”
Prognosis (1pt): “90% grow out of it by age 5”; specific; confident; emotional turning point of the consultation
Closing question with pause (1pt): “Before you go — anything I haven’t answered?” + genuine 3–5 second pause
🟩 Realistic outcome: Mrs. Sharma leaves with eHF prescription; eczema cream; 2-week appointment booked; breastfeeding guilt resolved; saying “I finally have an actual answer.”
💊 Drug Quick-Pick
Reviewed: July 2026 · citations verified against current NICE / UK guidance